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ABSTRACT
Prospective medicinal compounds progress through multiple testing phases before
becoming licensed drugs. Testing of novel compounds includes a preclinical phase
where the potential therapeutic is tested in vitro and/or in animal models in vivo to
predict its potential efficacy and/or toxicity in humans. The failure of preclinical models
to accurately predict human drug responses can lead to potentially dangerous
compounds being administered to humans, or potentially beneficial compounds being
kept in development abeyance. Moreover, inappropriate choice in model organism for
studying disease states may result in pushing forward inappropriate drug targets and/or
compounds and wasting valuable time and resources in producing much-needed
medications. In this dissertation, models for basic science research and drug testing are
investigated with the intention of improving current preclinical models in order to drive
drugs to market faster and more efficiently. We found that embryonic rat hippocampal
neurons, commonly used to study neurodegenerative disease mechanisms in vitro, take
3-4 weeks to achieve similar, critical ion-channel expression profiles as seen in adult rat
hippocampal cultures. We also characterized a newly-available commercial cell line of
human induced pluripotent stem cell-derived neurons for their applicability in long-term
studies, and used them to develop a more pathologically relevant model of early
Alzheimer’s Disease in vitro. Finally, we attempted to create an engineered, layered
neural network of human neurons to study drug responses and synaptic mechanisms.
Utilization of the results and methods described herein will help push forward the
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development of better model systems for translation of laboratory research to
successful clinical human drug trials.
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CHAPTER 1 – GENERAL INTRODUCTION

Medical advancements in developed countries, coupled with a greater public awareness
of health issues (smoking, drinking, diet, exercise etc.) means people are living longer
than they were 40 years ago [1]. US residents born in 1970 were expected to live 70.8
years on average. By 2008, the average life expectancy of an American resident rose to
78 years. With this ageing population, comes a significant increase in the incidence rate
of neurological disorders, since most neurodegenerative conditions are age related. In
2000, there were 4.5 million US residents with Alzheimer’s Disease (AD). By the year
2050, this number is expected to almost triple to 13.2 million [2]. For such a severe
problem facing aging populations there is a serious lack of effective treatments or
therapies. As of 2015, there are only 5 FDA-approved drugs for treatment of AD. These
5 drugs treat the symptoms of AD but their capacity for preventing further damage is
debated [3]. Currently, the production of better drugs for AD prevention and symptom
alleviation is prohibited by the poor availability of suitable models of the complex human
central nervous system (CNS) for both drug screening and disease modeling purposes.
Drug

development,

from

identification

of

new

chemical

entities

(NCEs)

to

commercialization of an FDA licensed treatment, is a long and costly process; current
estimates suggest the complete procedure can cost up to $1.2 billion per drug over a 10
to 12 year period [4-6]. Drug attrition from development protocols (due to safety
concerns, lack of significant observed benefit, etc.) drives this cost up. The market
analysis firm Frost & Sullivan has estimated the price of failure at $50-70 million per
1

drug, with about 90% of candidate compounds failing at pre-clinical development stages
[7]. Unfortunately, a significant number of compounds that progress to clinical trials also
fail. Only 1 in 5 compounds entering clinical trials ever typically reaches the market [4,
5, 8]. Although some of this failure can be attributed to poor clinical trial design, patient
drop out etc., safety pharmacology concerns remain the major cause of drug attrition
during clinical development and validation of NCEs (responsible for about 30% of all
drug attritions) [9]. The fact that so many potentially dangerous compounds are not
selected out during preclinical development highlights an inability for current preclinical
techniques to adequately predict compound efficacy and/or toxicity in humans.
The gold standard for preclinical evaluations is a combination of in vitro analysis and
animal testing. Small animal (mouse and rat) studies are incredibly useful as predictors
of human development and tissue responses. Rodent models have significant
advantages for their use in that they are genetically similar to humans, have a relatively
short life span for rapid assessment, and can be inbred to be more genetically
consistent from one sample to the next. However, such models have been repeatedly
shown to be poor predictors of human responses to drugs [10].
Murine and other animal models are poor predictors of human drug responses for many
reasons. For example, gene expression responses to multiple inflammatory pathways
are similar in humans, whereas in mice, different pathways are triggered during
inflammation events [11]. In the referenced study, results from non-correlative tests
performed in mouse models were used to screen pre-clinical drug candidates for their
ability to block inflammatory responses in humans. Of the nearly 150 clinical trials
2

testing compounds that were prescreened in this manner, not one succeeded in clinical
trial.
Moreover, though animal models have their place in basic biological research and
predictive drug screening, these animals can be used at inappropriate, underdeveloped
stages which fail to reflect .advanced development. In the case of studying
neurodegenerative disease in vitro, early-stage embryonic rat tissue is often used to
study disease mechanisms which implicate ion channels not yet maturely expressed
(discussed in further detail in Chapter 2). Results obtained from such studies may
generate misleading data and exacerbate the issue in translating results from animal
models to successful clinical results in humans.
Furthermore, for rare conditions, such as Huntington’s Disease (HD), the animal models
which exist do not replicate the symptoms of the disease in just one organism or
species [12]. Multiple models must be utilized in order to begin to elucidate potential
therapeutic targets for HD treatment. Both small rodent models and large animal
models, such as pig, sheep, and monkeys, have been developed to begin to mimic the
disease state.
Other animal models do not account for human variability. Amyotrophic lateral sclerosis
(ALS) is hugely heterogeneous where most cases are sporadic and only about 10% are
familial. Superoxide dismutase 1 (SOD1) mutations found in familial ALS patients only
accounts for a small percentage of patient mutations, and has been found to have over
150 pathogenic variations [13, 14]. As such, standard SOD1 mouse models of ALS fail
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to recapitulate the complexity and genetic variability of this disease, severely limiting the
translational relevance of data obtained using this model [15, 16].
As an alternative to in vivo testing, the in vitro analysis of single human cells and
monolayers removes issues with non-correlating data between species [17].
Furthermore, such assays are useful for the study of cellular behavior and phenotype
without the complication of tissue-tissue interplay and whole body metabolic dynamics.
Using standard culture systems, the metabolic and functional development, as well as
drug responses, of individual cells and tissues can be analyzed in isolation. The
development of human induced pluripotent stem cell (hiPSC) technologies in recent
years has served to increase the availability of human cell types for such analyses [18].
Human iPSCs can be derived from multiple sources including skin fibroblasts [19],
extra-embryonic tissues from umbilical cord and placenta [20], blood cells [21], and
urine-derived cells [22, 23]. A variety of different methods have also been developed to
improve the efficiency of iPSC generation, including viral and lentiviral integration, nonintegrating viral vectors, and protein- and small molecule-based reprogramming [24].
These cells have also greatly increased the potential for in vitro preclinical screens to
predict human responses to drugs and to accurately model genetic variability between
patients [25, 26]. Since hiPSCs cells can be isolated and transformed from a specific
patient into a cell type of interest, it has been suggested that patient-specific modeling
could aid physicians in recommending effective, non-toxic drug treatment to patients in
the near future.
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However, despite the potential of hiPSC technologies to improve preclinical screening
methods, issues with maturity, a lack of structural organization (particularly for wellordered tissues such as CNS), and an inability to effectively model interactions between
supporting cell types has so far reduced the utility of these human cell cultures for such
applications [27, 28]. Typically, in vitro cell-based models function with only a fraction of
in vivo performance levels, which reduces the ability for such assays to accurately
predict functional responses. For example, skeletal muscle and cardiac models usually
exhibit reduced contractile functionality compared with native tissues [29-31]. Similarly,
neuronal models often display altered spike burst activity [32]. Finally, as is the case for
certain animal models, observed compound effects in vitro have not correlated closely
with in vivo outcomes [33].
There is a clear need for a better preclinical model. Body-on-a-chip technologies hold
potential for improving preclinical assessment of NCE efficacy, as well as absorption,
distribution, metabolism, and excretion (ADME) in human systems. Interconnected
organ-on-a-chip microdevices, which mimic tissue structure and function, enable the
detailed assessment of compound, complex effects, and facilitate study of tissue-tissue
metabolic cross-talk in a controlled and fully-defined system. The successful
development of these systems is predicated on the development of suitable cell culture
environments. Such environments must be capable of maintaining stable and
phenotypically mature cell populations in configurations that enable physiologicallyrelevant assessment of functional changes in response to chemically, physically, or
pathologically induced stress.
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Over the past decade, substantial progress has been made in the development of
bioengineered culture platforms that offer more accurate representations of a variety of
human tissues. Such models include representations of human heart, lung, skeletal
muscle, liver, gastrointestinal tract, kidney, and CNS. However, none of the published
platforms have so far have been adopted as standardized models for the tissue they are
emulating. This is due to a number of factors including cost of fabrication, reliability,
suitability for commercial requirements, and complexity. The major factor limiting market
penetration of these models, however, is that very few have demonstrated an ability to
develop structural, metabolic, and functional phenotypes that adequately recapitulate
that of the native tissue. Without this ability, such models are likely to be incapable of
providing accurate data in terms of predicting drug effects in humans, over and above
what is possible with conventional cell culture methods.
The widespread adoption of more advanced cell culture models is therefore predicated
on a capacity to demonstrate engineered tissue development that closely mimics what
is observed in vivo in a cost-effective and reliable way. Such systems not only hold the
potential to revolutionize the drug development process, but also hold the key to
improving our ability to study tissue development, maintenance, and breakdown in
disease.
Specifically, the pathophysiological mechanisms of many neurodegenerative disorders
are not fully understood, which makes their effective treatment difficult. In order to better
understand the causes of neurodegenerative disease, and so identify suitable targets
for therapeutic treatment, improved models of early disease stages are required. To this
6

end, these dissertation studies were developed to attempt to address current limitations
in the in vitro modeling of neural tissue in both healthy and diseased states. In order to
focus the project, the following four specific aims were addressed:
1) Examine the differences in ion channel expression and network connectivity in
adult vs. embryonic rat hippocampal cells by measuring network connectivity on
MEAs in response to ion channel drug challenges as a means to assess model
maturity.
2) Characterize the functional competence of human stem-cell derived pyramidal
“hippocampal-like” neurons and characterize their development and maturation in
different culture conditions in vitro.
3) Determine effects of amyloid beta on the electrical properties of human stem-cell
derived pyramidal “hippocampal-like” neurons (from Aim 2) in vitro.
4) Build a layered brain model using human stem-cell derived pyramidal
“hippocampal-like” neurons with specific focus on the establishment of chemical
or electrical stimulation parameters to induce and maintain Long-Term
Potentiation (LTP) on MEAs.
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CHAPTER 2 – THE COMPARISON OF NMDA AND AMPA CHANNEL
EXPRESSION AND FUNCTION BETWEEN EMBRYONIC AND ADULT
NEURONS UTILIZING MICROELECTRODE ARRAY SYSTEMS
Note: The contents of this chapter, with minor changes, was also submitted in partial
fulfillment of Darin Edwards’s dissertation in Summer 2011.

Introduction

A common limitation of neuronal MEA systems as well as neuroscience research in
general has been the reliance upon neurons derived from embryonic tissue [34-36].
While neurons derived from embryonic sources are fully differentiated, they are
developmentally immature, with transcriptional profiling indicating two-thirds of genes
are only expressed postnatally and >95% of the expressed genes showing highly
significant changes during postnatal development [37]. When evaluating the machinery
responsible for synaptic transmission, AMPA channel expression is limited at birth, only
increasing postnatally [38]. The gene expression for the NMDA channel subunits NR2A
and NR2B was not detected until near birth at E21-22, with expression not peaking until
P20 [39]. In vitro, NR2A/B channels are detected at only very low levels until after 2
weeks in embryonically derived neurons [40]. Gene expression for the axonal sodium
transporter subunit 1 begins around P15, then increasing until P30 [41, 42]. In vitro,
expression patterns for all genes, specifically axonal and synaptic channels responsible
for signal transmission, is similar to that seen in vivo, with gene expression showing
significant changes over the course of weeks [39-41, 43-45]. While embryonic rat tissue
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is relatively easily obtainable and easy to culture and maintain, the usefulness of these
developmentally immature neurons for studies of neuronal electrical activity and
synaptic transmission is restricted by the limited expression or lack of expression of
certain channels responsible for synaptic transmission in the adult brain. In addition,
using these developmentally immature neurons in studies of neurodegenerative
diseases or drug discovery can yield results that are difficult to correlate with the
function or action of mature neurons in adult brain tissue. In fact, because of this lack of
MNDA expression the utilization of embryonic or neonatal neurons yield promising in
vitro epilepsy models [46, 47].
We have developed a long-term hybrid in vitro system utilizing mature, terminally
differentiated neurons derived from adult rat hippocampal tissue in dissociated culture
[48,

49].

Whereas

most

electrophysiological

studies

rely

upon

patch-clamp

electrophysiology [50, 51], a method which is labor-intensive, requires specialized
training, and cannot be used to monitor neuronal function over more than a few hours at
a time, we utilized microelectrode arrays (MEAs). MEAs are innovative tools used to
perform electrophysiological experiments for the in vitro study of both neuronal activity
and connectivity in populations of neurons [35, 52] for extended time periods (days –
months) [53-56].
We concurrently measured spontaneous network activity from both embryonic and adult
neurons on MEAs in the presence/absence of synaptic transmission antagonists against
NMDA and AMPA channels. In addition, we evaluated both embryonic and adult
neurons for NMDA channel subunit expression and AMPA channel subunit expression
9

over 36 days in vitro (DIV). Adult neurons cultured in defined medium in vitro, displayed
expression patterns consistent with mature neurons in vivo, were electrically active, and
formed functional synaptic connections [57]. Our results indicate that neurons derived
from embryonic tissue did not express mature synaptic channels for several weeks, and
consequently their response to synaptic antagonists was significantly different than that
of neurons derived from adult tissue sources. These results establish the usefulness of
this unique hybrid system derived from adult hippocampal tissue for drug discovery and
fundamental research. Moving toward using a high-throughput hybrid in vitro system will
expand and improve drug testing and basic research by providing a viable, easily
manipulatable alternative to expensive, resource intensive in vivo testing. Uses for
these systems include studies into the mechanisms of learning and memory formation
[58] and investigations into drug discovery, neurodegenerative diseases, and biosensor
applications [34, 53, 54].
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Materials and Methods

Embryonic rat hippocampal dissociated cell culture
All research was approved by the Institutional Animal Care and Use Committee at the
University of Central Florida and conformed to NIH guidelines. Embryonic hippocampal
neurons were cultured using a protocol described previously [59, 60]. Pregnant rats, 18
days in gestation, obtained from Charles River were euthanized with carbon dioxide and
the fetuses were collected in dissecting medium made with ice-cold Hibernate E
(BrainBits) supplemented with B27 (2%), Glutamaxtm (2 mM), and antibiotic-antimycotic
(1%) (Invitrogen). Each fetus was decapitated and the whole brain was transferred to
fresh ice cold dissecting medium. After isolation, the hippocampi were enzymatically
digested at 37°C for 10 minutes with papain (2 mg/mL, Worthington 3119), Hibernate-E
without calcium (BrainBits) and 2 mM Glutamax (Invitrogen). Hippocampi were quickly
transferred to fresh dissection medium to halt enzymatic digestion. Hippocampal
neurons were dissociated by triturating the tissue using a fire-polished Pasteur pipette.
After centrifugation (300 x g, 4°C), cells were resuspended in culture medium
(Neurobasal Medium (Gibco)/B27/Glutamaxtm/antibiotic-antimycotic) and plated on
MEAs (see below).
Adult rat hippocampal dissociated cell culture
Adult neurons were extracted, dissociated, cultured, and maintained using a protocol
and medium similar to a protocol described previously [49, 61]. Briefly, the hippocampus
of adult rats (Charles River, age 6-12 months) were dissected and homogenized into
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small tissue fragments in cold medium (~4ºC) consisting of Hibernate-A (HA, BrainBits)
supplemented with B27 (2%), Glutamaxtm (2 mM), and antibiotic-antimycotic (1%). The
tissue was digested for 30 minutes at 37°C in calcium-free Hibernate-A (BrainBits)
containing papain (2 mg/mL). Following digestion, the tissue was washed three times
with cold HA media to remove any active enzyme. Next, the tissue was suspended in
dissociation medium, (Hibernate-A Brain Bits (HA) supplemented with B27 (2%, Gibco
17504-044), Glutamax (2mM, Gibco 35050-061), Antibiotic / Antimycotic (1%, Gibco
15240-096),

Z-Asp(OMe)-Gln-Met-Asp(OMe)

fluoromethyl

ketone

(4mM,

Sigma

C0480), Z-Val-Ala-Asp fluoromethyl ketone (5mM, Sigma C2105), Dextrose-coated
Cerium Oxide Nanoparticles (100nM, a gift from Dr. Manuel Perez), and (±)-6-Hydroxy2,5,7,8-tetramethylchromane-2-carboxylic acid (Trolox, 70nM, Sigma 238813)) and
broken apart into individual cells through mechanical dissociation with fire-polished
Pasteur pipettes. The dissociated cells were suspended in plating medium, NeurobasalA Medium with osmolarity adjusted to 295 mOsm (Gibco, 10888-022), B27 (2%),
Glutamax (2 mM), antibiotic-antimycotic (1%), Recombinant Human Brain-Derived
Neurotrophic Factor (20 ng/ml, Cell Sciences CRB600B), NT-3 (20 ng/ml, Cell Sciences
CRN500B), bFGF (5 ng/ml, Invitrogen 13256-029), Insulin-like Growth Factor (20 ng/ml,
Sigma I2656), Dextrose-coated Cerium Oxide Nanoparticles (100 nM), Trolox (70 nM,
Sigma 238813), and then deposited onto DETA (N-1 [3-(trimethoxysilyl) propyl]diethylenetriamine, United Chemical Technologies Inc., Bristol, PA, T2910KG) coated
glass cover slips, according to published protocols [62, 63]. After 30-45 minutes, the
cover slips were washed with warm HA by gently swirling the medium to remove tissue
debris. Following this washing step fresh plating medium was applied and remained for
12

the first 3 DIV. On 3 DIV the medium was removed and replaced by maintenance
medium (composed of all components of plating medium except Trolox and Dextrosecoated Cerium Oxide Nanoparticles) supplemented with 5 µM Roscovitine (Rosc,
Sigma, R7772) to halt cell division. After 4 DIV, the adult hippocampal neurons on the
DETA cover slips were passaged to MEAs. Briefly, neurons were dislodged from the
DETA with trypsin (0.05% trypsin / EDTA in HBSS, Gibco, 25200). Trypsin inhibitor
(trypsin inhibitor, soybean, Gibco, 17075-029) in Dissociation Medium at 0.5 mg/mL
deactivated the trypsin. The dislodged neurons were collected and spun at 500 x g for 5
minutes. The supernatant of deactivated trypsin in HBSS was discarded, and the
neuronal cell pellet was suspended in 1 ml plating medium for culturing.
Immunocytochemistry and Laser Scanning Confocal Microscopy
To prepare cells for immunocytochemical characterization, cover slips were rinsed twice
with Phosphate Buffered Saline (PBS). Cells were fixed with 4% paraformaldehyde for
ten minutes at room temperature, and subsequently rinsed three times with PBS. Cells
were permeabilized for five minutes with 0.5% Triton X-100 in PBS, and were then
blocked for two hours in 5% normal goat serum (Gibco) in PBS. Anti-neurofilament-M
(Chemicon, AB5735, 1:500), anti-synaptophysin (Chemicon, MAB368, 1:300), and
either anti-NMDAR2A (Chemicon, AB1555P, 1:200), anti-NMDAR2B (Chemicon,
AB15557P, 1:200), or anti-glutamate receptor 2/3 (Chemicon, AB1506, 1:50) were
added in blocking solution for 12 hr at 4°C. After 3 washes with PBS, fluorescently
labeled secondary antibodies (Invitrogen, A11011 (594 nm), A21449 (647 nm), and
A11029 (488 nm), in blocking buffer were applied (1:200) for two hours. Vectashield
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mounting medium with DAPI (H1200, Vector Laboratories, Burlingame, CA) was used to
mount the cover slips onto slides. Fluorescent images were acquired with the UltraView
spinning disc confocal system (PerkinElmer) with AxioObserver.Z1 (Carl Zeiss) stand,
and a Plan-Apochromat 40x/1.4 Oil DIC plan-apochromat objective with 26 µm
resolution. Z-stack projections of the scanned images were generated and modified
within the Volocity image processing program (PerkinElmer).
MEA Plating and Culture Maintenance
The MEA chips (Axion Biosystems) provided 64 platinum-black coated gold-electrodes
with a diameter of 30 µm, organized in an 8 by 8 array with 200 µm pitch. Clean MEAs
were sterilized with 70% alcohol and then incubated with 1 ml poly-L-lysine (100 µg/ml)
for 30 minutes. An area just large enough to cover all electrodes was additionally coated
with 3 µl laminin (2 µg/ml) over night. Embryonic rat hippocampal neurons were plated
directly on MEAs at a density of 500 cells/mm2. Adult rat hippocampal neurons were first
cultured on DETA coated cover slips for initial recovery and removal of debris.
Embryonic tissue did not require this pre-plating step as there is very little debris
generated from the culturing process. After 4 days on DETA cover slips, the adult
neurons were passaged onto MEAs at a density of 500 cells/mm 2 (Figure 2-1). Every 23 days, half the medium was replaced with fresh maintenance medium supplemented
with 2 µM Rosc. Supplementing the adult neurons with 25 µM glutamate (N-Acetyl-Lglutamic acid, Aldrich, 855642) at 2 DIV increased the electrical activity of the adult
neurons [48].
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MEAs were incubated with their covers off to allow gas exchange but covered upon
removal from the incubator to reduce contamination, media evaporation, and gas
exchange. The head stage of the recording system (Axion Biosystems) was pre-heated
to 37 °C before MEAs with adult or embryonic hippocampal cultures were investigated.
Experimental Procedure
The activity of neuronal networks was recorded at 25 kHz using the software Axion’s
Integrated Studio (AxIS). Signal amplitudes 6 times larger than the standard deviation of
the base line were detected as action-potential (AP) spikes. The spike data was then
imported into Matlab 2010b (The MathWorks) for further processing. Baseline
spontaneous activity in adult and embryonic neurons was recorded for 3 minutes on 5
consecutive days per week, starting at 7 DIV. The synaptic antagonists D-(-)-2-Amino-5phosphonopentanoic acid (D-AP5, 25µM, Tocris Bioscience, 0106) and 6-Cyano-7nitroquinoxaline-2,3-dione disodium (CNQX, 25µM, Tocris Bioscience, 1045) were
separately administered to both adult and embryonic neurons on 14 DIV and at various
time points between 30 and 60 DIV. Three minute recordings were made to quantify the
effect from these antagonists on spontaneous activity. If necessary, additional baselines
were recorded prior to the administration of antagonists. After MEA measurements were
recorded, the antagonists were washed from the neurons with an entire media change;
24 hours later, the activity of the neurons had returned to baseline levels.
Evaluation and statistics
Data analysis was performed off-line using unpublished Matlab functions to evaluate
spike files created during each MEA recording. In brief, each 3 minute dataset was
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processed to extract the following parameters: “active channels” (a number from 0 to
64); “AP frequencies” (reciprocal inter-spike intervals); “Burst” (where at least 10% of
the active channels showed more than 1 AP with 1 ms); “Burst duration” (time-interval
from the first AP in a burst to the last AP in a burst); “Average burst frequency” (the
reciprocal time-difference between two subsequent bursts); “In-burst frequency”
(amount of APs within a detected burst divided by the duration of that burst); “Non-burst
frequency” (reciprocal inter-spike intervals between APs that were not associated with
bursts). In about 25% of the adult cultures and 14% of the embryonic cultures, portions
of the neuronal networks detached from the substrate over time and especially after
about 6 weeks. In order to accommodate the different numbers of active channels
between MEAs all values were corrected for the amount of active channels on an MEA.
For each of the 3 minute recordings, a representative results chart was produced as
shown in figure 2-3. Effects from synaptic antagonists were measured as the percent of
active channels or AP frequency of treated embryonic or adult cultures versus the
baseline activity of the same cultures recorded before administration of the antagonist.
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Results

Dissociated neuronal cultures from adult and embryonic sources recovered on MEAs
and formed networks on MEAs at a density of 500 cells / mm 2 (Figure 2-1). . Threeminute recordings of spontaneous activity were taken of each MEA, 5 times per week,
for up to 70 DIV. Phase-contrast pictures of the MEAs were taken after each recording
for a daily assessment into the condition of the cells as well as verification of physical
contact between cells and electrodes (Figure 2-1). Neurons, both adult and embryonic,
were stable and electrically active on MEAs for up to 90 DIV (data not shown).
Spontaneous activity of Adult and Embryonic Neurons
Spontaneous firing activity started in both the adult and embryonic neurons between 7–
10 DIV. Movement of MEAs from the incubator to the heated recording stage and the
subsequent 3 minute recording period did not significantly affect the pH or temperature
of the medium, represented by consistent baseline activity. However, brief increases in
baseline neuronal activity were observed as a result of medium changes. Over the more
than 2 month culture period, embryonic MEAs (n = 6) consistently displayed a higher
number of active channels, with an average of 37±8 channels active per MEA versus
15±5 channels in adult MEA cultures (n = 9). Action potential (AP) firing frequencies in
embryonic cultures with approximately 2 - 4 Hz were higher than in adult cultures with
AP firing frequencies of 1 - 2 Hz. Spontaneous bursting occurred about one week earlier
in adult cultures as opposed to embryonic cultures. The burst development over the first
6 weeks was consistent between the two types of neuronal networks (Figure 2-3A).
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After the 6th week, however, bursts in the adult cultures appeared less often, whereas
the burst frequency in the embryonic cultures increased further. For both embryonic and
adult cultures, the duration of bursts decreased over the time span of 10 weeks (Figure
2-3B). The bursts of embryonic cultures were on average 3 - 5 times longer as opposed
to bursts in adult cultures. While burst durations in the embryonic cultures were
consistently variable (about ±1s) over the 10 weeks of experimentation, bursts in the
adult cultures decreased in length. This focusing of bursts in adult cultures was
accompanied by a steady increase of the in-burst firing frequencies over time (Figure 23C). The in-burst frequencies of adult cultures recovered within the first 2 weeks,
whereas embryonic cultures recovered slower and reached mature in-burst levels after
about 6 weeks. The non-burst firing frequencies (APs not related with bursts) were
consistent over the entire time for the adult cultures, but decreased steadily in the
embryonic cultures (Figure 2-3D). Overall, the burst activity focused and matured earlier
and more consistently in adult cultures on MEAs, whereas embryonic cultures showed a
slower, more chaotic maturation.
NMDA and AMPA channel activity and expression in adult and embryonic neurons
Antagonists were administered to embryonic and adult cultures on MEAs in separate
experiments: 25 µM D-AP5 (NMDA channel antagonist) and 25 µM CNQX (AMPA
channel antagonist). D-AP5 (25 µM) caused a significant decrease in the number of
active channels in both adult and embryonic MEA cultures (Figure 2-4 A,B). Adult
cultures lost a greater percentage of channel activity (90±6 % on 14 DIV, 82±6 % on 3060 DIV) versus embryonic cultures (65±4 % on 14 DIV, 36±7 % on 30-60 DIV).
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Changes in the AP frequency also varied with lower frequencies in adult cultures (76±8
% on 14 DIV, 82±17 % on 30-60 DIV) which were significantly different from the
measured effect on embryonic cultures (Figure 2-4 C,D). On 14 DIV, the firing rate of
embryonic neurons increased 90±6 %, while in 30-60 day old cultures the firing rate
decreased 70±7 %. While NMDA channels were expressed at low levels in embryonic
neurons on 14 DIV, the level of expression was not nearly as high as in adult neurons
on 14 DIV (Figure 2-5 A,B). The difference in NMDA channel expression (NR2A and
NR2B subunits) in adult and embryonic neurons in vitro likely caused the contrasting
reaction to D-AP5 in the two populations of neurons. Because adult neurons expressed
a greater number of NMDA channels, their reaction to the competitive NMDA antagonist
D-AP5 was much more pronounced.
Addition of CNQX caused the activity of far fewer channels to be lost in both adult and
embryonic MEA cultures as compared to D-AP5 (Figure 2-4 A,B). Adult cultures lost a
greater percentage of channel activity (52±3 % on 14 DIV, 24±5 % on 30-60 DIV)
versus embryonic cultures (23±5% on 14 DIV, 0±7% on 30-60 DIV). Changes in AP
frequency in both the adult and embryonic cultures were not affected by CNQX after 14
DIV (Figure 2-4D). The activity of the neurons was only slightly decreased in both
embryonic and adult cultures between 30 to 60 DIV (31±6% drop in adult MEAs, 47±5%
drop in embryonic MEAs). While expression of the AMPA channel subunits GluR2/3
was not observed in embryonic neurons on 2 DIV, expression had increased to mirror
adult levels by 14 DIV (Figure 2-5 C).
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Discussion

The results demonstrated that adult neurons cultured from the hippocampus of rats
recovered functionally and had the capacity to fire spontaneously on MEAs over 60 DIV.
Additional culture techniques were used to allow adult neurons to recover from initial
plating trauma and reduce debris before being densely deposited on the MEAs and to
improve recovery of electrical activity in vitro. Adult cells were first pre-cultured at a lowdensity and then were passaged and deposited onto MEAs at 500 cells / mm 2, a density
high enough to allow the formation of multiple synaptic connections. This step allowed
for the removal of debris from the cultures and allowed recovery after dissociation to
enable high survival in MEA cultures. The application of a pre-plating step along with
the supplementation of glutamate in the culture medium promoted elevated electrical
activity in the adult neurons [48]. After 7 to 10 DIV, sporadic spontaneous firing activity
was detected, and stable reliable recordings were evident after this point.
Since neuronal MEA systems have typically relied upon neurons derived from
embryonic tissue [34-36, 53-55], we compared our novel adult hippocampal MEA
system to traditional embryonic MEA systems. Recording from both adult and
embryonic MEAs were made daily through 90 DIV (data not shown) and fully
characterized out to 60 DIV. Embryonic MEAs consistently displayed higher numbers of
active channels, with an average of 40 channels active versus 20 active on adult MEAs.
The majority of other parameters, including AP frequency, activity, average burst
frequency, and average in-burst frequency, all displayed similar characteristics between
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the adult and embryonic MEA systems. This new adult MEA system, at its core,
exhibited similar firing characteristics to the more traditional embryonic MEA systems.
However, the adult cultures developed the capability of synchronized bursting about one
week earlier than the embryonic cultures. Bursting in neuronal networks is usually seen
as an indicator for maturity [64]. Spontaneous periodic synchronized bursting during
formation of mature patterns of connections in cortical cultures [65]. While embryonic
neurons regenerate, fire APs and eventually develop synchronized bursts on MEAs, the
developmental maturity of these neurons had not been robustly established. In the
hippocampus of embryonic rats, neural progenitors differentiate into neurons between
E15-E18 [37, 43, 66]. While these cells obtained from embryonic rats are fully
differentiated, they are developmentally immature, with transcriptional profiles showing
two-thirds of genes are only expressed postnatal and >95% of expressed genes show
highly significant changes during postnatal development [37]. When examining the
machinery responsible for synaptic transmission, gene expression for the NMDA
channel subunits NR2A and NR2B was not detected until near birth on E21-22, with
expression not peaking until P20 [39]. During this developmental period, NR2B was
predominantly expressed in the early postnatal brain while NR2A expression increased
to eventually outnumber NR2B, with each subunit lending different kinetics of
excitotoxicity, neurotoxicity, and plasticity [67]. In vitro, NR2A/B channels are detected
at only very low levels until after 2 weeks in embryonic neurons [40]. AMPA channel
expression is also limited at birth, only increasing postnatally [38]. Gene expression for
the axonal sodium transporter subunit 1 begins around P15, increasing till P30 [41, 42].
In vitro, expression patterns for all genes, specifically axonal and synaptic channels
21

responsible for signal transmission, is similar to that seen in vivo, with gene expression
showing significant changes over the course of weeks [39-41, 43-45]. The importance of
these dynamics of neuronal maturation highlights the need for gene and protein
expression in study population of neurons to mirror that in mature adult neurons in vivo.
If embryonic neurons do not express the same machinery responsible for electrical
activity or signal propagation in adult neurons, then their response to neurotoxic agents
or drug therapies may not be correlative to responses in the mature adult brain.
Our method of culturing adult neurons resulted in a system where NMDA and AMPA
channel subunits were expressed throughout the lifespan of the culture. NMDA channel
subunits NR2A and NR2B as well as AMPA channel subunits GluR2/3 were expressed
on and after 2 DIV. This contrasted greatly from neurons derived from embryonic tissue,
with delayed NMDA and AMPA channel expression until 14 DIV and later. Responses
of neurons to NMDA and AMPA channel antagonists were found to be significantly
different in embryonic neurons as compared to adult neurons, with each antagonist
decreasing activity in adult neurons to a greater degree than in embryonic neurons. Our
results show that embryonic neurons in culture develop a mature profile of ion channel
subunits after 3-4 weeks. Therefore, embryonic neurons should not be employed for
experiments until they have fully matured in culture, especially in studying
neurodegenerative diseases such as Alzheimer’s where synaptic protein profiles may
play a critical role in the process of synaptic failure [68-72].
In comparison to embryonic MEA systems, our method of using adult hippocampal
neurons on MEAs, is more appropriate to acquiring data with mimics the adult brain.
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While preparation of these MEAs was slightly more complicated than embryonic
neuronal MEAs, the end result yielded a long-term screen methodology that is more
biomimetic of the synaptic machinery responsible for critical synaptic function required
in learning and memory [73-76]. Additionally, due to the earlier development of bursts
and general maturation, this system can facilitate quicker, more reliable, and more
correlative

investigations

into

drug

discovery,

neurotoxic

agents,

and

neurodegeneration. Finally, this method can be used in the future to allow for the adult
human neuronal networks cultured on MEAs.
In conclusion, we have demonstrated critical differences between adult and embryonic
neurons and their respective synaptic connections which could be highly relevant in
neurodegenerative disease research. By demonstrating the similarities and differences
between adult and embryonic neurons and the response of each to synaptic
antagonists, the value of this adult neuron culture system has been established for
application in neuronal regeneration and drug discovery studies. The significance of this
finding is that most in vitro neuronal research utilizes embryonic hippocampal neurons
for periods of less than 7-11 weeks. By incorporating adult neurons into an MEA
system, a long-term system has been created to enable the screening of a large
number of cells and the study of pathogen and drug effects on the same population of
cells over an extended period of time. This screen could find important applications in
pharmaceutical drug development by providing an in vitro test platform for investigations
into neurodegenerative disease, traumatic brain injury, stroke, drug discovery, and
fundamental research.
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Figure 2-1. Adult and embryonic MEA culture and life cycle. Adult neurons: Mature
terminally differentiated adult neurons were extracted from the hippocampus of adult
rats and plated onto DETA cover slips. After 4 days the neurons were passaged from
these cover slip(s) onto MEAs that had been coated with PDL / laminin (for cell
adhesion). Embryonic neurons: Neurons from the hippocampus of embryonic day 18 rat
fetuses were extracted and plated directly on MEAs that had been coated with PDL /
laminin. Electrical recordings of spontaneous neuronal activity were performed for up to
3 months. In addition, ion channel receptor antagonists were introduced and their
effects were measured against baseline electrical activity. 64-channel axion biosystems
MEAs were used.
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Figure 2-2. Phase contrast images of cultures on MEAs after 3 DIV and 30 DIV.
Neurons were applied between 500 to 1000 cells / mm 2. Cells attached and
regenerated on the PDL / laminin surface covering the MEAs, seen in the dense
collection of cells covering the electrodes. Each 64-Channel MEA is arranged in an 8 x
8 array of electrode 30 µM in diameter and spaced 200 µM apart. The MEA was
sampled 25,000 times per second, at 16 bits of depth. Scale bar = 50 µm.
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Figure 2-3. MEA data processing: The spontaneous activity of embryonic and adult
neurons was recorded for 3 minutes each day over the study period. Each 3 minute
dataset was processed in a 3-step method. This method allowed inactive or noisy
channels to be excluded. After processing, the following parameters were extrapolated:
“active channels” – a number from 0 to 64. Channels with less than 7.5 APs per minute
were treated as inactive. “AP Frequency” – number of total measured APs divided by
recording time. The mean and stdev of that number is independent from active
channels. “AP Activity” – is 1 divided by the time between two subsequent APs, or
frequency 1/s. “Burst” – where more than 1 AP occurs within 1 ms. “average burst
frequency” – 1 divided by the time-difference between two subsequent bursts. “In-burst
frequency” – amount of APs within a burst divided by the duration of that burst. “Nonburst frequency” – like the activity, but considers on APs that are not associated with
bursts. “Burst duration” – time-interval from the first AP in a burst to the last AP in a
burst.
26
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Figure 2-4. Basic firing patterns of embryonic and adult hippocampal neurons on
MEAs over time. The spontaneous activity of embryonic and adult neurons was
recorded for 3 minutes each day over the study period. The activity data from each day
was processed to filter out inactive channels. (A) Number of active channels. (B)
Frequency of APs. (C) Average activity, or 1 divided by the time between two
subsequent APs (frequency 1/s). (D) Burst frequency. (E) In-burst frequency. MEA
number to plating date: Embryonic: MEA 23 – 3/14, MEA 29 – 3/14, MEA 30 – 3/14,
MEA 31 – 3/14, MEA 21 – 2/14, MEA 26 – 2/14, MEA 27 – 2/14. Adult: MEA 22 – 1/31,
MEA 28 – 2/17, MEA 25 – 2/17, MEA 24 – 2/17, MEA 40 – 3/21, MEA 33 – 3/21, MEA
34 – 3/21, MEA 36 – 3/21, MEA 37 – 3/21, MEA 38 – 3/21. Gaps in graphs indicate
activity was not recorded on that day.
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Figure 2-5. Comparison of the impact on adult or embryonic spontaneous activity
from addition of synaptic antagonists. Active channels (A,B) or AP frequencies (C,D)
were evaluated in adult or embryonic hippocampal neuron MEA systems on either 14 or
30-60 DIV in the presence of D-AP5 (25 µM), CNQX (25 µM), or Bicuculline (50 µM) in
culture medium. Adult neurons showed significantly decreased active channels and AP
frequency due to D-AP5 in both early 14 DIV cultures as well as older 30-60 DIV
cultures. This drop in activity was significantly different from embryonic 14 DIV, where
fewer active channels were lost and activity increased in the remaining channels. The
AMPA-channel antagonist CNQX also caused a decrease in spontaneous activity. The
drop in activity between adult and embryonic cultures was, however, only reflected in
the loss of more active channels in the adult system. AP frequency declines were
consistent between the two culture systems. Bicuculline had limited effect on
spontaneous activity in both embryonic and adult neurons.
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Figure 2-6. Expression of presynaptic proteins and postsynaptic channel
subunits in embryonic and adult neurons in vitro: NR2A, NR2B, or GluR2/3 (red);
synaptophysin (green); neurofilament-M (far-red); and DAPI (blue) expression after 2,
14, and 36 DIV. NMDAR2A (A) and NMDAR2B (B) were not expressed in embryonic
neurons on 2 DIV and were not strongly expressed on 14 DIV (when compared to
channel expression in adult neurons). After 36 DIV, the channels were expressed by the
embryonic neurons at similar levels to the adult neurons. The AMPA receptor subunits
GluR2/3 (C) were expressed by embryonic neurons by 14 DIV. These postsynaptic
channel subunits were all found in adult neurons from 2 – 36 DIV. Synaptophysin and
Neurofilament-M expression grew stronger as both the embryonic and adult neurons
recovered and regenerated in vitro. Scale bars 17 µm.
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CHAPTER 3 – MORPHOLOGICAL AND FUNCTIONAL
CHARACTERIZATION OF HUMAN INDUCED PLURIPOTENT STEM
CELL-DERIVED NEURONS (ICELL NEURONS) IN DEFINED CULTURE
SYSTEMS
Introduction

It is necessary to determine the system requirements for human stem cells for long-term
in vitro culture. Current efforts to streamline and accelerate established drug screening
protocols and body-on-a-chip device development [77-80] are predicated on the
development of robust and fully-functional human cell types derived from both
embryonic and induced pluripotent (iPSC) stem cells. To this end, the characterization
of competent sources of terminally-differentiated human pyramidal neurons is
necessary for the development of neuronal network models for these devices and for
high throughput single cell assay systems. In addition, the utilization of neurons derived
from iPSCs enables the in vitro study of neurodegenerative conditions, such as
Alzheimer’s disease, derived directly from patient populations. Baseline characterization
of a stable cell source is a necessary first step for pre-clinical drug testing applications,
as well as for the establishment of personalized drug development protocols utilizing
these patient-specific stem cells.
Neurons derived from hiPSCs by Cellular Dynamics International (CDI, Madison, WI),
termed iCell Neurons, offer one commercial source for such cells. These hiPSC-derived
populations are composed of GABAergic and glutamatergic post-mitotic neurons which
rapidly regenerate post-thaw. Previous data obtained from these cells using culture
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parameters established by the manufacturer indicates their functional characterization
over two weeks in vitro, including evidence for their ability to generate three major
voltage-dependent currents (Nav, Cav, and Kv) [81]. However, analysis of neuronal
performance over a two week period in a single culture environment is insufficient if
these cells are to be considered for incorporation into chronic drug evaluation studies in
vitro [82, 83]. Careful assessment of maturation end points and cell survival over an
extended time-course is necessary to justify incorporation of CDI’s hiPSC-derived
neurons into body-on-a-chip and other devices for chronic drug toxicity and efficacy
studies.
The development of complex in vitro systems requires the establishment of reproducible
surface modifications, medium formulations and cell propagation protocols [84].
Assessment of effective culture parameters is necessary in order to evaluate the best
system for developing controlled neuronal networks for in vitro drug evaluation
protocols. The chemical silane N-1(3-[trimethoxysilyl]propyl)-diethylenetriamine (DETA),
can be used to create a cytophilic culture surface, providing a fully-defined and
reproducible alternative to biopolymer coatings [85]. Previously, DETA has been used in
conjunction with cytophobic surfaces to successfully culture as well as pattern cells into
controlled configurations [86], providing the means to develop in vitro engineered cell
networks for a variety of advanced culture applications [87, 88]. Furthermore, previous
work has demonstrated that DETA is capable of promoting the survival and maturation
of primary neurons in culture for extended periods [61, 83, 89]. DETA, an analogue of
spermine, has been shown to promote neuron survival in vitro through interactions with
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NMDA-receptor complexes, and is also known to promote increased longevity in a
number of model organisms by reducing the overproduction of harmful reactive oxygen
species and autophagy regulation [90-92]. For these reasons, DETA is an ideal surface
modification for use in the establishment of complex, multi-organ in vitro platforms for
drug-evaluation protocols. The medium composition is also a key variable in
establishing a defined culture system. The development of fully-defined, serum-free
systems is critical for the generation of reliable pre-clinical data, as serum-containing
medium comprises unknown, variable factors which may confound results, thereby
limiting the ability to draw robust conclusions from such studies [18].
In this study, the survival, purity and electrophysiological development of hiPSC-derived
neurons over a one month culture period was evaluated under various controlled
conditions. Cells maintained in the manufacturer’s culture conditions were compared
with those kept in a fully-defined, serum-free cell culture environment that was
developed to promote the long-term survival of primary adult hippocampal neurons [61,
83]. The collected data demonstrate that these hiPSC-derived neurons can be grown on
both biopolymer and chemically-defined surfaces for at least one month. During this
time, the cells maintained a consistent neuronal population and underwent
electrophysiological maturation, characterized by evaluation of the number of
repetitively firing neurons in culture, changes in major voltage currents, and decreased
action potential (AP) duration. These cells maintain a high level of viability consistently
for at least 28 days. A subset of the cultured cells expressed markers specific to layer 5
cortical neurons, indicating a degree of neuronal sub-type heterogeneity within the
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population. The collected electrophysiological and biochemical data indicate these cells
possess a pyramidal phenotype and increasingly mature over one month in vitro [93].
However, differences in functional maturity and survivability were noted over the
conditions examined. Based on these findings, these hiPSC-derived neurons present an
excellent source of human pyramidal-like neurons for use in novel in vitro applications
such as body-on-a-chip platform development or for use in functional high throughput
screening systems.
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Materials and Methods

Surface modification
Glass coverslips (Thomas Scientific 1217N81, 18 mm, no. 1.5) were cleaned using an
oxygen plasma cleaner (Harrick PDC-32G) for 10 min at 100 mTorr. The N-1(3[trimethoxysilyl]propyl)-diethylenetriamine (DETA, United Chemical Technologies Inc.,
Bristol, PA, T2910KG) self-assembled monolayers were produced by reaction of
plasma-cleaned glass with a 0.1% (v/v) mixture of the DETA in freshly distilled toluene
(Fisher T2904) as described by Ravenscroft et al. (1998).[88] The DETA-coated
coverslips were heated to just below the boiling point of toluene (70°C), thoroughly
rinsed with toluene, reheated to 70°C, and then oven dried. Surfaces were validated
prior to use in cell culture using contact angle measurement and X-ray photoelectron
spectroscopy as described previously.[94]
Cell culture and maintenance
Human hiPSC-derived neurons were obtained from CDI in frozen vials containing at
least 2.5 million cells (catalogue number: NRC-100-010-001). Cells were handled
according to the manufacturer’s user’s guide. Briefly, cells were removed from liquid
nitrogen storage (-196°C) and thawed for 3 minutes in a 37°C water bath. Cells were
gently transferred to a 50 ml Falcon tube where 1 ml of CDI’s Complete Maintenance
Medium (MM) was added drop-wise to the cell suspension. Cells were swirled gently to
minimize osmotic stress and an additional 8 ml of medium was slowly added. Cells were
plated at a density of 700 cells per mm2 on DETA or poly-L-ornithine (PLO)/laminin
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(0.01% PLO and 3.3 μg/ml respectively) coated coverslips and placed in an incubator
set to 37°C and 5% CO2. PLO/laminin surfaces will be referred to as “laminin surfaces”
throughout the text. Cells were given complete medium changes after 24 hours in vitro,
as per the manufacturer’s instructions, and were subsequently fed every 3-4 days with
half changes of the medium. Hybrid Systems Laboratory medium 1 (HSL1) was
prepared as described by Edwards et. al, with the exception of the inclusion of bFGF
(See Supplemental Table 1).[83] This medium was originally developed as a
maintenance medium for the long-term support in culturing of adult rat hippocampal
neurons. CDI MM is proprietary and therefore cannot be detailed herein, but is
commercially available.
Cell viability and neuritic outgrowth analysis
In order to assess the ability of hiPSC-derived neurons to survive in different
combinations of medium and surface compositions, cells were grown in MM and HSL1
on DETA and laminin-coated surfaces. Phase contrast images were taken with an
inverted microscope (Zeiss Axiovert) after 1, 3, 7, 10, 14, 21, and 28 DIV, counted and
normalized to day 1 cell counts for each culture. The longest neurite from a minimum of
75 cells per condition was measured (ImageJ; National Institutes of Health, Bethesda,
MD) from phase contrast images taken at 1, 3, and 7 DIV.
Immunocytochemistry
Cells were fixed using 4% paraformaldehyde for 20 min, rinsed with and stored in
phosphate-buffered saline (PBS) at 4°C until they were used for immunocytochemical
analysis. Cells were then permeabilized for 20 min with 0.2% Triton X-100 in PBS and
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incubated at room temperature for 2 hrs in blocking buffer (2.5% donkey serum, 2.5%
goat serum, and 0.5% BSA) to prevent non-specific antigen binding. Primary antibodies
(chicken anti-microtubule associated protein 2 (anti-MAP2) polyclonal (abcam, ab5392,
1:1000), rabbit anti-glial fibrillary acidic protein (GFAP) polyclonal (Millipore, AS5804,
1:1,000), rat anti-CTIP2 monoclonal (abcam, ab18465, 1:100), and mouse anti-SATB2
monoclonal (abcam, ab51502, 1:100)) were diluted in blocking buffer then added to the
permeabilized cultures. Cells incubated with primary antibody solutions were maintained
overnight at 4°C. Cells were then rinsed four times with PBS and incubated with their
respective secondary antibodies diluted in blocking serum: goat anti-chicken Alexa 488
(A11039), goat anti-chicken Alexa 568 (A11041), donkey anti-rat Alexa 488 (A21208),
donkey anti-mouse Alexa 568 (A10037), and donkey anti-rabbit Alexa 568 (A10042) at
1:200 (Molecular Probes) for 2 hrs at room temperature. After rinsing four times in PBS,
cells were mounted with Vectashield hard-set mounting medium with DAPI (HI500,
Vector Laboratories, Burlingame, CA) onto glass slides and allowed to dry before
imaging. The cells were photographed using a Zeiss LSM 510 confocal microscope.
Expression of the respective antibodies was then quantified manually to compare the
effects of medium and surface on the proportion of cells staining positive for CTIP,
SATB2, GFAP, and MAP2. Positive and negative controls were run to ensure
secondary antibodies were not significantly contributing to background staining and that
primary antibodies were functioning as anticipated (Supplemental Figure 3-8). Only cells
with intact nuclei staining positive for DAPI were counted and cumulative frequency
analysis was performed to ensure enough cells were qualified to appropriately represent
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the mean. A minimum of 75 cells per condition per replicate were counted from three
separate cultures.
Patch-clamp electrophysiology
Whole-cell patch clamp recordings were performed in a chamber on the stage of an
upright microscope (Axioscope FS2, Carl Zeiss, Göttingen, Germany). The chamber
was filled with the same medium as utilized for cell culture (+10 mM HEPES buffer). The
osmolarity was approximately 296 mOsm and 233 for the HSL1 and MM respectively.
The intracellular solution composition was: 140 mM K-gluconate (Sigma, G-4500), 4
mM NaCl (Fisher, S642-212), 0.5 mM CaCl2 (Fisher, C70-500), 1 mM MgCl2 (Sigma,
63068), 1 mM EGTA (Fisher, 02783-100), 5 mM HEPES acid (Fisher, BP310-100), 5
mM HEPES base (Fisher BP410-500), 5 mM Na2ATP (Fisher, BP413-25). Osmolarity
was adjusted to between 25-40 mOsm less than extracellular solutions. The nearphysiological pH of the medium was monitored with phenol red indicator. Borosilicate
glass patch pipettes (BF150-86-10; Sutter, Novato, CA) were prepared using a Sutter
P97 pipette puller. A pipette resistance of 4–10 MΩ was used for all intracellular patch
clamp recordings. Voltage clamp and current clamp experiments were performed with a
Multiclamp 700B amplifier (Axon Instruments, Foster City, CA, USA). Signals were
filtered at 2 kHz and digitized at 20 kHz with an Axon Digidata 1322A interface. To
generate a single action potential (AP), a 3 ms depolarizing current pulse of sufficient
intensity (1-2 nA) was applied. Inward and outward currents were evoked by a series of
250 ms depolarizing steps from -70 to +170 mV with +10 mV increments. Before seals
(1 GΩ) were made on cells, offset potentials were nulled. Capacitance subtraction was
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used in all recordings. Data recording and analysis were performed using pClamp 10
software (Axon Instrument, Foster City, CA, USA).
Statistical analysis
To determine significant differences in cell viability, expression levels of neuronal
markers, and rates of repetitive AP firing, Chi-Squared Goodness of Fit tests were
performed across surface treatments and medium compositions at each time point
examined. Multiple regression analyses were also performed on repetitive firing data to
assess temporal trends. Longest neurite measurements were calculated from a
minimum of 75 cells per condition using image analysis software (ImageJ; National
Institutes of Health, Bethesda, MD). Longest neurite and electrophysiology data were
log-transformed where necessary to reduce variation and/or normalize data before
running two-way ANOVA followed by Tukey’s test for multiple comparisons; one-way
ANOVAs were run to compare day 7 and 28 data for full width half max (FWHM) and
AP rise time. For each experiment, data was collected from a minimum of three
independent cultures and all electrophysiological measurements were averaged from a
minimum of 15 cells. For all data analyzed, a P value of less than 0.05 was considered
significant. Data is presented as mean ± standard error of the mean.
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Results

Human iPSC-derived neurons were maintained on DETA or laminin coated coverslips
for 28 days DIV. Cells established on these surfaces were either maintained in CDI
Complete Maintenance Medium (MM) or a serum-free medium developed by the Hybrid
Systems Laboratory (HSL1) optimized for the maintenance of primary adult rat
hippocampal neurons [83]. Electrophysiological and biomolecular analysis of these cells
was performed at various time-points throughout the culture period in order to fully
evaluate cell viability, morphology, identity and functional maturity over time in vitro.
Cell purity and neuritic outgrowth analysis
The commercially-available iCell neurons are known to be relatively pure neuronal
populations;

however,

as

culture

conditions

were

changed

from

what

was

recommended by the manufacturer, cell purity was reevaluated. In order to ascertain
the neuronal purity of the cultures maintained in the different conditions, cells were fixed
and stained for the neuron-specific marker MAP2 and the glial marker glial fibrillary
acidic protein (GFAP) following 7 and 28 DIV (Figure 3-1). Cells stained at a rate of
close to 100% positive for MAP2 whereas almost no positive staining (only two cells
across all conditions; Supplemental Figure 3-8A) was observed for GFAP in any culture
system combination, indicating the high degree of neuronal purity of the iCell Neurons.
In order to assess the effect of surface and media compositions on neuritic outgrowth,
the longest process from a minimum of 75 cells was measured for each condition at 1, 3
and 7 DIV. Analysis of the collected data indicated that a significant difference in neuritic
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extension existed between cells maintained on laminin and DETA surfaces and
between those fed with MM and HSL1 (p < 0.001, Figure 3-2). Biopolymer coated
surfaces promoted a greater level of neurite growth over 7 DIV than did DETA treated
surfaces. Similarly, medium composition had a significant effect on process
development. On laminin surfaces, cells maintained in MM had an average neurite
length of 123.60 µm (±1.65) after 7 DIV. Cells maintained in HSL1 were significantly
shorter after 7 DIV (p < 0.001), with a mean length of 103.65 µm (±5.59). On DETA
surfaces, cells grown in MM for 7 DIV had an average neurite length of 55.87 µm
(±1.67) which was significantly shorter than cells maintained in HSL1 which possessed
an average neurite length of 79.03 µm (±2.55). Although both medium and surface
conditions had a significant effect on neurite outgrowth, the effect of surface treatment
was substantially greater than that of medium composition, with laminin promoting
roughly 40% longer neurites than DETA after 24 hours in culture.
Cell survival and viability over 28 day culture period
Phase contrast images of cultured cells were collected at 1, 7, 10, 14, 21 and 28 DIV
and then counted in order to assess viability across all surface types and media
compositions. The number of cells per mm 2 was calculated and normalized to results
from day 1 to ascertain whether cell number per unit area increased or decreased in
relation to the cell numbers present at the time of plating across different culture
parameters (Figure 3-3).
In all culture conditions examined, cell survival was found to drop over the 28 day
culture period at a rate of 0.8% cells per day in HSL1 and 1.6% cells per day in MM; this
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difference in rate of cell death was statistically significant (p = 0.04). Cell survival was
significantly improved when cells were maintained in HSL1 (p < 0.001), where the
cultures indicated a 40% improvement in cell viability at 28 DIV. The disparity observed
between DETA cultures using different media indicates an important interplay between
surface and medium composition for maintaining cells in vitro. The best conditions for
promoting long-term cell survival was HSL1 on DETA surfaces, which promoted
significantly greater survival over 28 DIV than all other conditions (p < 0.001). As these
hiPSC-derived cells are non-proliferative and the factors added to the HSL1 medium are
not known to induce cell proliferation, the fact that no significant increase in cell number
was observed at any time in any culture condition reiterates that cell division was not
occurring in these cultures regardless of medium compositions or surfaces tested.
Characterization of neuronal phenotype
Characterization experiments were conducted using immunocytochemical analysis to
identify whether the neurons expressed markers for specific cortical layers following 7
DIV. All cultures examined were negative for the upper cortical layer marker SATB2
(embryonic rat hippocampal cultures served as positive controls; Supplemental Figure
3-8B), but a subpopulation was positive for the deep layer V marker of subcortically
projecting neurons, CTIP2 (Figure 3-4). No significant differences in CTIP2
immunostaining were observed between different culture parameters, with all conditions
containing roughly 44% CTIP2 positive cells.
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Electrophysiology
Electrophysiological maturity of cells maintained under different culture conditions was
assessed after 7, 14, 21 and 28 DIV. Representative recordings from cells at 7 DIV and
28 DIV reveal general trends in electrophysiological maturation: increased inward and
outward current (Figure 3-5, top), increased capacity for repeat firing (Figure 3-5,
middle), and ability to fire robust APs (Figure 3-5, bottom)..
Detailed analysis of electrophysiological data obtained from endpoint (28 DIV) studies
indicated significant differences in the properties of cells maintained with the medium
and surface combinations utilized in this study (Figure 3-6). Laminin surfaces in
combination with HSL1 (-54 mV ± 1, n = 21) produced cells with significantly higher
resting membrane potentials than laminin with MM (-51 mV ± 2, n = 16, p = 0.02), DETA
with MM (-46 mV ± 1, n = 15, p = 0.001) and DETA with HSL1 (-49 mV ± 2, n = 16, p <
0.001). Similarly, laminin with HSL1 cultures produced significantly greater peak inward
currents than all other culture conditions investigated (-1513 pA ± 177, p < 0.005).
DETA with MM cultures produced significantly smaller peak inward (-454 pA ± 44, p <
0.001) and outward (522 pA ± 77, p = 0.001) currents than all other experimental
conditions, suggesting this combination of medium and surface type is less capable
than others investigated for promoting functional maturation of iCell Neurons. However,
no significant differences were observed in AP peak amplitudes from cells maintained in
different conditions, indicating that even the poorer culture conditions investigated were
able to support robust electrical function in these cells. Analysis of iCell Neurons
electrophysiological properties over time in culture (Supplementary Figure 3-9) indicates
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the relative functional stability of these cells over this 28 day culture period. Some
variability is apparent between culture conditions, with MM/ DETA producing
consistently poorer inward and outward currents over time, supporting the observations
made from 28 day analysis discussed above. However, the collected data suggest all
investigated parameters were capable of maintaining functional performance of these
cells in vitro over the time course investigated.
Assessment of rates of repetitive firing of APs across all conditions highlighted a trend
toward increased incidences over time in vitro (p = 0.004, Figure 3-6E). Rates of
repetitive fire increased significantly across conditions from 7 to 14 DIV and again from
21 to 28 DIV (p < 0.001), indicating the improved functional performance of cells over
these time periods. The fact that further maturation of electrophysiological profiles
occurred after the 2 week culture period previously examined [81] highlights the
importance of long-term evaluation of cells in order to identify appropriate experimental
end-points for future studies. The majority of patched cells fired repetitively at 28 DIV,
with the exception being those maintained in MM on DETA where only 40.0% of
patched cells displayed such behavior. This observation correlates with cell viability
data for this culture condition, which indicated the largest decrease in cell numbers at
this time point, and highlights the unsuitability of this surface and medium combination
for maintaining long-term cultures of these iPSC-derived neurons in vitro. Additionally,
the medium used had a significant effect on the number of cells capable of repetitive
firing (p = 0.03), with an increase of approximately 15% of the total cells repetitively
firing in HSL1 medium versus MM. The surface on which the cells were grown was not
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a significant contributor to the ability of the cells to repetitively fire (p = 0.15). The
highest rate of repetitive firing was 81.3% of patches seen in cells maintained in HSL1
on DETA at 28 DIV. Cells in MM or HSL1 on laminin had repetitive firing rates of 62.5%
and 66.7% respectively at this time point. Given this high level of functional maturity at
this late stage, the data suggests 28 DIV as a suitable sampling time-point for end point
analysis of these in vitro cultures.
The maturation of AP waveforms between 7 and 28 DIV were investigated in cells
maintained across all described conditions. Results indicate that cells cultured in
HSL1/laminin conditions exhibited the shortest AP FWHM after 7 days (4.77 ms ± 0.42),
and maintained this short FHWM to 28 DIV (4.77 ms ± 0.31, Figure 3-7A, p < 0.05).
Although HSL1/laminin showed no maturation of AP waveform between 7 and 28 days
(as measured by FWHM), its performance at 7 days was already significantly improved
over other conditions (p < 0.05). This result therefore suggests that HSL1/laminin
culture conditions promote rapid maturation of AP waveform, which is then maintained
up to 28 DIV. Notably, HSL1/DETA promoted improvement of FWHM between 7 (10.14
ms ± 1.69) and 28 DIV (5.98 ms ± 0.70) (p < 0.05), but the data recorded at 28 DIV was
not significantly different from that recorded from cells in the HSL1/laminin condition.
The significant difference between HSL1/DETA and HSL1/laminin at 7 days (p < 0.05)
suggests maturation was slower on DETA than on laminin in this medium. All cultures
grown in MM, regardless of surface treatment, were unable to reach AP duration times
similar to those grown in HSL1 at 28 DIV (p < 0.05). There were no significant
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differences in any medium or surface combination that significantly effected AP rise time
(Figure 3-7B,p < 0.05).
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Discussion

The ability to use mature, fully functional human neuronal tissue in vitro can be a vital
tool in the development of high-throughput drug test-beds that mimic in vivo
biocomplexity. Development of robust assays using hiPSC-derived neurons however
could give a higher level of statistical homogeneity when translating bench-top research
to clinical studies, and may uncover new options for personalized medicine in
neurodegenerative disease, psychiatric disorders, and stroke recovery. Establishment
of such cell lines is predicated on the full characterization of molecular markers and
electrophysiological function to allow accurate comparison to relevant clinical and preclinical data.
This study highlights that commercially available hiPSC-derived neurons demonstrate
variable viability, neuritic development and functional maturation depending on the
combination of medium and culture surface to which they are exposed. The cultured
cells were found to be almost a pure neuronal population, as indicated by consistent
MAP2 marker expression and lack of significant GFAP expression across all
experimental conditions and time points examined. Between 7 and 28 DIV, the number
of neurons, as a percentage of the cultured cell population remained constant,
suggesting the absence of proliferative neuronal precursor cell types. This stability is
important for body-on-a-chip devices where stable populations are necessary to
facilitate long-term assessment of drug effects [77-80].
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Typical neuronal morphology was observed across all biological and chemicallymodified surfaces and media types examined. However, differences in neurite
outgrowth were observed across examined culture surface and medium combinations.
Laminin-treated substrates promoted a 40% increase in neurite extension compared
with DETA counterparts after 24 hours, and this difference persisted across the
subsequent 6 days analyzed. This observation correlates with previous data highlighting
the role of laminins in promoting neuritic development both in vivo and in vitro studies
[95, 96]. Control over extensive neuritic outgrowth could be advantageous for body-ona-chip applications since laminin proteins could be deposited in areas where outgrowth
is necessary over prolonged distances. While this attribute has its advantages, use of
laminin in body-on-a-chip devices as a culture substrate may cause neurite tracks to
extend beyond desired targets. While is it true that physical barriers may be utilized to
control neuronal architecture, this is not always a feasible option where intricate nanoor micro-scale features may be destroyed by the addition of such barriers. Restrained
neuritic development, such as that observed on DETA-treated surfaces, may be
advantageous for chip-based technologies since multi-organ biomimetic devices require
the manipulation of surface cues at key areas to aid efforts in directing neuritic
development to reach target cell types. Such cues can be altered to suit the complex
architecture of chip based devices and be tailored to suit specific experimental
parameters.
Significant differences in neurite growth rates were likewise observed between media
types investigated in this study. MM showed a significant improvement over HSL1 for
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promoting neurite outgrowth from cells cultured on laminin surfaces. Conversely, HSL1
promoted significantly greater outgrowth on cells maintained on DETA. This disparity
indicates a level of synergistic effect between surface and medium on cellular
development in vitro. Since HSL1 was developed for use with DETA surfaces, and the
MM was similarly optimized for laminin substrates, it seems logical that these
combinations

would

perform

better

than

their

counterparts

(MM/DETA

and

HSL1/laminin). However, it also points out the danger from simply substituting one
variable in a culture system and expecting positive results.
Human iPSC-derived neurons grown in MM have been assessed over short (2 week)
time courses [81]. Cell viability data from this study highlights that while MM is likewise
capable of promoting high levels of cell survival over 4 week culture periods, HSL1
medium promotes significantly greater cell survival over the same period. This is not
surprising, since HSL1 medium was specifically developed for promoting the long-term
survival and development of hippocampal neurons in culture [61, 83]. The observed
differences in cell survival highlight the importance of medium optimization for specific
experimental protocols in order to ensure detected changes are due to experimental
variables rather than unoptimized culture conditions.
RT-PCR and immunocytochemical analysis of iCell Neurons as reported by CDI
demonstrate

the

culture

as mixed

populations primarily of

GABAergic and

Glutamatergic neurons. Further gene expression analysis indicates the iCell neurons
are representative of a forebrain identity as evidenced by regional expression of genes
such as LHX2, FOXG1, OTX2, GBX2, and EN1 (private conversation with CDI).
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However, further understanding of neuronal cell type specificity is important for
assessing whether these cells are applicable to specific assays and drug toxicology
experiments. Positive staining for the layer 5 specific pyramidal marker, CTIP2,
indicates that roughly 44% percent of the cell population possesses a deep layer
cortical phenotype in all tested culture conditions. All cultures examined were negative
for the upper layer marker, SATB2, suggesting the remaining cells did not possess an
upper layer cortical phenotype. The presence of a significant number of upper and lower
level pyramidal markers which are stable in culture would be beneficial for investigators
looking to model complex layered brain architecture such as that of the CA1 region of
the hippocampus [97, 98]. However, given that the examined cultures were almost 99%
positive for MAP2 but only 44% positive for CTIP2, there remains some ambiguity as to
the specific neuronal identity of a significant proportion of these iCell neurons. Further
in-depth characterization of these neurons would be useful for a complete
understanding of the phenotypic origin of the cell sub-populations.
Data from patch-clamp experiments indicated that these hiPSC-derived neurons reach
electrical functionality at early time points. By 7 DIV, hiPSCs are able to fire robust APs
with peak amplitudes relatively similar to those seen in mature slice cultures of postnatal
Wistar rats (reported as 91.35 mV ± 3.36)[99] and macaque monkeys (reported as 83.1
mV ± 1.6 )[100] (Supplemental Figure 3-9).

However, they continue to undergo

functional maturation as evidenced by the increased inward and outward currents
(Supplementary Figure 3-9), increased rates of repetitive firing over 28 DIV (Figure 3-6),
and, in some cases, a reduction in FWHM. When examining the rate of development of
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repetitive firing cells on different surfaces, it is apparent that laminin promoted a more
rapid maturation of cultured neurons. By 14 DIV, laminin treated cultures already
possessed repetitive firing behavior in roughly 54% of patched cells, compared with less
than 40% in DETA treated cultures. The rate of repetitive fire on laminin surfaces
levelled off in later time points whereas DETA cultures improved, suggesting a slower
rate of maturation on these surfaces, but supporting earlier claims of the suitability of
DETA for maintaining functional cultures in long-term systems. Regardless of
surface/medium composition, all conditions reached numbers of cells capable of repeat
APs firing similar to male guinea pig slice cultures where the number of cells repetitively
firing was 38 – 59%, depending on the CA3 subregion of the hippocampus [101].
In developing cortical neurons, APs become larger and shorter in duration as a result of
changes in expression of voltage-activated Ca2+ channels and rectifying K+ channels
[102]. Therefore, shortening of FWHM in cultured neurons is an important indicator of
cellular maturation. Cells cultured in HSL1 medium exhibited an AP duration profile
closer to that seen in mature rat and mouse slices [103, 104], indicating improved
electrophysiological function in these cells. In HSL1 medium, cells on DETA surfaces
exhibited improved FWHM between 7 and 28 DIV (Figure 3-7A). However, laminin
surfaces already possessed short FWHM values by 7 days, indicating faster AP
waveform maturation on this surface. This observation supports the repetitive firing data
discussed above, and suggests that laminin surfaces promotes more rapid maturation
of neuronal electrophysiological function. Interestingly, although AP duration was
affected by medium composition and surface type, AP rise time was unaffected (Figure
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3-7B). This result could indicate incomplete maturation that is not promoted by the
culture conditions tested, or more likely that these cells already exhibit a mature sodium
conductance profile capable of producing rapid AP rise times.
This study highlights the importance of considering surface characteristics and medium
composition in terms of their likely effect on experimental parameters. Although these
cells are functional at early time points, investigators should consider the maturation of
electrical properties as cells may function differently at earlier vs. later time points in
different

culture

conditions.

This

is

especially

important

when

investigating

neurodegenerative diseases or any condition where functional performance is expected
to change over time or a more mature functional phenotype is required.
The ability for hiPSC-derived neurons to survive in various culture conditions is
necessary since complex body-on-a-chip devices require compatibility with different
platforms, media types, and environments other than those defined by the
manufacturer. Our results indicate that hiPSC-derived neurons display typical neuronal
morphology and remain mitotically stable and differentiated for extended periods.
Moreover, their ability to respond to chemical cues makes them an ideal candidate for in
vitro modeling of complex neural architecture for body-on-a-chip applications. However,
these cells exhibit significant variance in the development of electrophysiological
performance over 28 DIV, and their ability to develop fully functional phenotypes is
heavily influenced by culture conditions. The collected data therefore highlights the
need to assess cellular performance under different culture conditions (e.g. surface and
media type) in order to achieve optimal cellular development and maturation and for
54

integration of human-based in vitro systems for next-generation drug-screening
applications.

Figure 3-1. Human iPSC-derived cells thrive on both DETA and biopolymer
surfaces. (A) Cells were cultured in MM on laminin, MM on DETA, HSL1 on DETA and
HSL1 on laminin through a 28-day period (B) Immunological analysis for neural markers
MAP2 (green) and GFAP (red) and the nuclear marker DAPI (blue). Images are
representative of 7 DIV (top) and 28 DIV (bottom) of both panels. (C) Cells which
stained positive for MAP2 were quantified at 7 and 28 DIV. Error bars represent SEM.
Scale bar = 20 µm.
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Figure 3-2. Neurite analysis of hiPSC-derived neurons. (A) The longest neurite
length was measured at 1, 3, and 7 DIV across all culture combinations of MM and
HSL1 media and DETA and laminin surfaces. (B) Representative phase images of cells
grown on laminin (left) and DETA (right) in MM at 1 DIV. Significant differences were
observed between surface types at 1 DIV and between both medium and surface types
at 3 and 7 DIV, *p < 0.001, **p < 0.001, ***p < 0.001. Error bars represent SEM. Scale =
30 µm.

Figure 3-3.. Viability of hiPSC-derived neurons over 28 DIV using different culture
parameters. Cells were counted per mm2 and normalized to day 1 counts to account
for culture variability and ease comparisons between conditions. No discernable
differences in survival trends were observed across all conditions examined over the
first 10 days in culture. After 28 DIV, HSL1 on laminin promoted a significantly higher
level of survival (*p < 0.001), whereas cells cultured in MM on DETA had significantly
fewer viable cells (**p < 0.001). Error bars represent SEM.
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Figure 3-4. Human iPSC-derived neurons express lower layer cortical pyramidal
phenotypic markers. Cells were stained for CTIP2 (green), SATB2 (red), and DAPI
(blue) at 7 DIV in maintenance medium (A, B) and in HSL1 (C,D) on laminin (A,C) and
on DETA (B,D) to assess potential layer identity. No cells stained positive for SATB2 in
any condition. (E) Intact nuclei stained positive for DAPI but were not CTIP2 positive
were quantified to estimate a percentage of CTIP2-positive neurons. Error bars
represent SEM. Scale bar = 20 µm.
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Figure 3-5. Representative electrophysiological recordings of hiPSC-derived
neurons. Patch-clamp recordings were taken at 7 (A) and 28 (B) DIV. (Top)
Voltage-clamp recording of inward sodium and outward potassium currents (-70 mV
holding potential, 10 mV steps). (Middle) Neurons were not likely to fire repeatedly in
response to depolarizing current injections at a -70 mV holding potential at 7 DIV versus
28 DIV. (Bottom) A single AP was generated using a 3 ms depolarizing current pulse of
1-2 nA. D. (Inset) Phase contrast image of patched neuron. Scale = 20 µm.
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Figure 3-6. Patch-clamp data collected from hiPSC-derived neurons grown in the
four different culture conditions. The resting membrane potential (A), AP amplitude
(B), peak inward current (C), and peak outward current (D) are represented at 28 DIV.
(E) The proportion of cells which repetitively fired APs in response to depolarizing
current injections at a -70 mV across all time points evaluated. HSL1/laminin cultures
had significantly higher resting membrane potentials (A, ***p = 0.02) and peak inward
currents (C, **p ≤ 0.005). Peak inward (C) and outward currents (D) were significantly
lower when grown in MM on DETA (*p ≤ 0.001 and *p ≤ 0.001, respectively). Rates of
repetitive fire showed a generally increasing trend over time across all conditions (*p ≤
0.005) with significant increases across conditions from 7 to 14 DIV and again from 21
to 28 DIV (*p ≤ 0.001), indicating the improved functional performance of cells over this
culture period. Error bars represent SEM.

59

Figure 3-7. Full width half max and rise time comparison of 7 and 28 DIV cultures
in various conditions. Values of FWHM (A) and AP rise time (B) were calculated for
each condition at both 7 and 28 DIV. Cells cultured in HSL1/DETA showed a significant
reduction in AP duration corresponding to a decrease in FWHM from 7 to 28 DIV. This
reduction in FWHM resulted in values similar to HSL1/laminin, the condition which
exhibited the shortest FWHM time. All cultures grown in MM, regardless of surface,
were unable to reach AP duration times similar to those grown in HSL1 at 28 DIV. AP
rise times were unaffected by culture medium or surface conditions. *p < 0.05. Error
bars represent SEM.

Table 3-1. Composition of HSL1 medium.
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Supplemental Figure 3-8. Immunostaining of human and embryonic rat neurons.
Only two human iPSC-derived neurons out of all conditions examined stained positive
for GFAP (green) (A). No human iPSC-derived neurons positively stained for the marker
SATB2, whereas positive control embryonic rat hippocampal cultures stained positive
for both SATB2 (red) and CTIP2 (green) (B). Scale bar = 20 µM.

Supplemental Figure 3-9. Patch-clamp data collected from hiPSC-derived neurons
grown in various conditions. The resting membrane potential (A), peak AP amplitude
(B), peak inward current (C), and peak outward current (D) are represented across all
time points evaluated. Error bars represent SEM.
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CHAPTER 4 – PHYSIOLOGICAL Aβ CONCENTRATIONS PRODUCE A
MORE BIOMEMETIC REPRESENTATION OF ALZHEIMER’S DISEASE
PHENOTYPE IN CULTURED HUMAN NEURONS
Introduction

Alzheimer’s disease (AD) is a worldwide pandemic estimated to have affected 26.6
million people in 2006. By the year 2050, this figure is projected to quadruple without
pharmacological intervention [105]. Given the increased rate of diagnosis and the rising
expense associated with long-term personal care, the cost of treating AD is estimated to
reach $1 trillion in the USA alone by 2050 [106].
Only five FDA-approved medications are currently on the market. Though these
medications are widely prescribed to treat the cognitive symptoms of AD, there is much
debate over their effectiveness [93, 107-109]. In spite of the significant progresses in
elucidating the biological mechanisms of AD [110, 111], no practical treatments exist
which prevent or significantly delay its progression.
Contributing to the dearth of effective medications for treating AD is the lack of robust,
biomimetic models that accurately recapitulate the pathophysiology of the condition in
human tissue. Without a reliable humanized model, progress in therapy development
and testing is seriously hindered. Current animal models, including a wide variety of
species

[83,

112],

poorly

represent

complex

human

neurochemistry

and

neurodegeneration [113]. As of March 2014, more than three dozen drugs have failed in
AD clinical trials despite positive pre-clinical data from over two dozen transgenic
models [114]. With recent advances in the development of robust, neuronal human
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induced pluripotent stem cell (hiPSC) lines [115-119], there is an opportunity to develop
a human-based in vitro disease model for AD which may lead to better translation of lab
research to clinical results.
Amyloid-β is known to be a crucial causative protein in AD development [120, 121].
Disease progression is linked to accumulation of Aβ and formation of plaques and
phosphorylated tau tangles, leading to reduced neuronal activity and eventually cell
death. Specifically, low-weight Aβ oligomers, not monomers [122] or fibrils commonly
associated with disease endpoints, have been shown to be the primary pathological
species [123-129]. Amyloid beta protein dimers directly isolated from AD patients have
been shown to impair synaptic plasticity and memory but not the amyloid plaque cores
from which they were derived [123]. In particular, Aβ 1-42 oligomers have been shown
to induce calcium dyshomeostatis by depleting endoplasmic reticulum calcium [130] in
rat cultures, were elevated in transgenic mice which had significant learning and
memory deficits [131] and correlate strongly with dementia in elderly patients [127, 132134].
Treatment of cultured neurons with Aβ has long been used as a means to model AD in
vitro. However, the fact that we see poor translation of in vitro studies to the clinic
suggests these models are poor representations of the disease. Studies commonly use
non-physiological Aβ concentrations to achieve neuronal impairment in vitro [135-140].
This is problematic because opposing effects have been reported when investigating
higher than physiologic concentrations of Aβ [83]. Furthermore, the high rates of cell
death and expression of tau tangles in response to such treatments is representative of
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late-stage AD. Targeting therapeutics to treatment of this late-stage phenotype is
inappropriate since neurological damage is already severe, and so likely to be
irreversible. Moreover, acute treatment with nonphysiologically relevant doses to
promote rapid neurodegeneration is fundamentally unrepresentative of AD progression
in vivo, and so poorly suited to mechanistic studies of early disease states. We
hypothesize that chronic exposure of human neurons to a physiologically representative
dose of Aβ will produce an in vitro phenotype which more closely represents early-stage
AD pathology, and therefore a more appropriate model for evaluating novel AD
therapeutics.
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Materials and Methods

Cell culture
Human iPSC-derived neurons (Cellular Dynamics International, iCell Neurons NRC100-010-001) were plated at 700 cells per mm2 according to manufacturer’s instructions.
Cells were plated in maintenance medium (NRM-100-121-001 with NRM-100-031-001)
and incubated overnight at 37°C 5% CO2. Plated cells were changed to Hybrid Systems
Laboratory Medium 1 (HSL1) without phenol red as phenol red may interact with
amyloidogenic compounds [141]. HSL1 was specifically developed to facilitate the longterm survival and maturation of hippocampal neurons [142] (Berry et al. 2015). Medium
was changed every 3-5 days and maintained over 28-30 days in vitro (DIV). Chronic
treatment of 10 nM Aβ, a dose close to physiological Aβ concentrations [143], began at
7 DIV to give cellular networks enough time to establish robust connections (Berry et al
2015). Acute, 48 hr treatments of 10 nM and 5 µM Aβ were performed 2 days prior to
patch clamp electrophysiology (26-28 DIV).
Surface modification
Cells were plated onto laminin-coated (Sigma, L2020, 3.3 µg/mL) coverslips which had
been treated with the self-assembled monolayer, N-1(3-[trimethoxysilyl]propyl)diethylenetriamine (DETA, United Chemical Technologies Inc., Bristol, PA, T2910KG).
Briefly, plasma-cleaned glass coverslips (Thomas Scientific 1217N81, 18 mm, no. 1.5)
were silanized with a 0.1% (v/v) mixture of DETA in freshly distilled toluene (Fisher
T2904) as described previously [144]. The DETA-treated glass was heated to just below
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the boiling point of toluene (70°C), rinsed with toluene, reheated to 70°C, and then dried
in an oven overnight at (100-105°C). Surfaces were validated via contact angle
measurement and X-ray photoelectron spectroscopy as described previously [145].
Laminin was added to DETA-treated glass overnight at 4°C. DETA has previously been
used for long-term culture of multiple cell types, including neurons [57, 61, 94, 97, 146],
and enhances the adsorption of laminin onto the culture surfaces (see Supplemental
Figure 4-5).
Amyloid-β oligomer preparation
Amyloid-β oligomers (Bachem, H-1368) were prepared as described previously [147].
Briefly, Aβ peptide was monomerized using HFIP (Sigma-Aldrich, 105228) and dried
overnight. Peptide films were further dehydrated with dry nitrogen and stored under
desiccant at -80°C until use. Peptide films were resuspended in dimethylsulphoxide
(DMSO) and diluted to 100 µM in Neurobasal A medium without phenol red (Invitrogen,
12349-015). Peptide suspensions were allowed to oligomerize for 24 hrs at 5°C before
use. Preparations of Aβ1-42 were centrifuged at 14,000 rpm to remove any large fibrils
and the supernatant was then diluted in phenol red-free medium for immediate use. The
final concentration of DMSO was ≤ 0.1%.
Oligomer characterization
Aβ protein was prepared using a protocol known to produce low-weight oligomers [147].
To confirm the success and quality of our oligomerization protocol, gel electrophoresis
of pure Aβ protein was performed, followed by a coomassie blue stain. MiniPROTEAN® 10-20% Tris-Tricine Precast Gels (Bio-Rad, 456-3113) were loaded with
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the purified Aβ peptide suspended in Tricine Sample Buffer (Bio-Rad, #161-0739), and
electrophoresed for 1-2 hrs at 120 V in Tris-Tricine SDS buffer (Sigma-Aldrich, T1165).
Gels were then stained with Coomassie Brilliant Blue (Bio-Rad, 161-0786), and
destained (Bio-Rad, Coomassie Brilliant Blue R-250 Destaining Solution 161-04381610438) to evaluate low-weight oligomer formation (Supplemental Figure 4-6).
MTT assay
MTT solution (Thiazolyl Blue Tetrazolium Bromide (Sigma, M5655) at 5 mg/mL in PBS)
was added to cultures at a 1:5 ratio and incubated for 2-3 hrs. The MTT solution/culture
medium was then removed and fresh lysis buffer (1% SDS and 0.57% glacial acetic
acid in DMSO) was added to wells, triturated, and transferred to a 96-well plate (Falcon,
3-353070). Cell viability was then assessed using a plate reader (Bio-Tek, KC4 Synergy
HT) to detect emission levels at 570 nm and thereby quantify purple formazan
byproduct levels in each sample. Emission levels were normalized to background levels
achieved when measuring MTT/culture medium solution from wells with no cells plated.
Immunocytochemistry
Cultures were fixed using 4% paraformaldehyde for 20 mins before being rinsed with
phosphate-buffered saline (PBS) at 4°C. Cells were then permeabilized for 20 mins with
0.2% Triton X-100 in PBS and incubated at room temperature for 2 hrs in blocking
buffer (2.5% donkey serum, 2.5% goat serum, and 0.5% BSA) to prevent non-specific
antigen binding. Primary antibodies rabbit monoclonal anti-microtubule associated
protein tau (abcam, ab32057, 1:250), and chicken polyclonal anti-beta-III tubulin
(Millipore, ab9354, 1:1,000) were diluted in blocking buffer then added to the
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permeabilized cultures and maintained overnight at 4°C. Cells were then rinsed four
times with PBS and incubated with their respective secondary antibodies diluted in
blocking serum: goat anti-chicken Alexa 568 (A11041) and donkey anti-rabbit Alexa 488
(A21206) at 1:200 (Molecular Probes) for 2 hrs at room temperature. After rinsing four
times in PBS, cells were mounted with ProLong® antifade reagent (Life Technologies,
P36930) onto glass slides. The cells were imaged using a Zeiss LSM 510 confocal
microscope. Expression of the respective antibodies was then quantified with ImageJ
[148] by measuring the integrated density and normalizing to cell number. Results are
expressed relative to values recorded for untreated controls. A minimum of 50 fields of
view at 40x magnification were quantified per condition.
Patch-clamp electrophysiology
Electrophysiological properties of hiPSC-derived neurons were investigated after 28-30
DIV. Whole-cell patch clamp recordings were performed on the 37°C heated stage of an
upright microscope (Axioscope FS2, Carl Zeiss, Göttingen, Germany). Extracellular
recordings were performed in the same medium used for cell culture (+10 mM HEPES
buffer), including drug treatments. The intracellular recording solution (140 mM Kgluconate, 4 mM NaCl, 0.5 mM CaCl2, 1 mM MgCl2, 1 mM EGTA, 5 mM HEPES acid, 5
mM HEPES base, and 5 mM Na2ATP) was loaded into borosilicate glass patch pipettes
(BF150-86-10; Sutter, Novato, CA) produced with a pipette puller (Sutter, P97). Patch
pipettes with a resistance in the range of 6–10 MΩ were used for all recordings.
Voltage-clamp and current-clamp experiments were performed with a Multiclamp 700B
amplifier (Axon Instruments, Foster City, CA, USA). Signals were filtered at 2 kHz and
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digitized at 20 kHz with an Axon Digidata 1322A interface. Offset potentials were nulled
before formation of a gigaΩ seal and fast and slow capacitance was compensated for in
all recordings. Membrane potentials were corrected by subtraction of a 15 mV tip
potential, calculated using Axon’s pClamp10 software (Axon Instrument, Foster City,
CA, USA). To generate a single action potential (AP), a 3 ms depolarizing current pulse
of sufficient intensity (1-2 nA) was applied. Inward and outward currents were evoked by
a series of 250 ms depolarizing steps from -70 to +170 mV with +10 mV increments.
Depolarization-evoked repetitive firing was recorded in current clamp mode. Gap-free
recordings of spontaneous activity of patched neurons were performed for up to 5 m
while holding the cell membrane at optimal threshold (between -45 and -50 mV). All
recordings and analysis were performed using pClamp 10.
Statistical analysis
One way analysis of variance (ANOVA) tests were performed to assess differences
between treatments of hiPSC-derived neurons followed by Student-Newman-Keuls
Method tests. Post hoc Student-Newman-Keuls Method tests were also performed on
data sets that did not have equal variance (resting membrane potential, MTT) but had a
normal distribution of data. Data that had equal variance but were not normally
distributed were analyzed using ANOVA on ranks, followed by the Dunn’s method for
multiple comparisons (inward and outward currents, max rep firing, rise time). Square
root transformations were performed on the spontaneous firing and maximum repetitive
firing data sets to properly condition them for ANOVA analysis. Statistical differences in
tau protein staining intensity between each Aβ treatment and untreated controls were
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independently assessed via student’s t-test. Each experiment included data collected
from at least 3 independent cultures. Data is presented as mean ± standard error of the
mean.
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Results

Cell morphology and viability
In all conditions, phase-contrast microscopy revealed cells which appeared healthy and
had extensive neuritic outgrowth over the 4 week culture period. Phase images showed
similar gross morphology across conditions, with no obvious aberrant morphological
changes upon addition of Aβ (Figure 4-1A). Assessment of cell viability by MTT assay
yielded no significant differences between control and treatment with 10 nM Aβ, both
acute and chronically (p > 0.05. Figure 4-1B). However, treatment with 5 µM Aβ
significantly reduced cell viability compared to control cultures (p = 0.005). In 5 µM Aβtreated cultures, viability dropped by 35.66% (± 5.75). Viability in acute and chronic 10
nM treated cultures were 103.93% (± 2.83) and 99.07% (± 3.96) respectively compared
to untreated controls (Figure 4-1B). These differences were not significant (p > 0.05).
These results indicate that chronic exposure to a pathological concentration of Aβ was
insufficient to induce significant levels of cell death over a 4-week culture period. Acute
Aβ treatment, with concentrations not representative of levels reported in human tissue,
led to significant cell death after just 48 hours in culture.
Electrophysiological function
Representative electrophysiological recordings of control and treated neurons highlight
(Figure 4-2A,B,C) the major differences in electrophysiological function quantified in
Figure 4-3. The resting membrane potential of cultured neurons was significantly
reduced in 5 µM Aβ-treated cultures compared to untreated controls (p = 0.034, Figure
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4-3A). Conversely, no significant difference in resting membrane potential was observed
for either acute or chronic 10 nM treatments (p > 0.05). Inward sodium and outward
potassium currents were significantly reduced in 5 µM Aβ-treated cultures compared to
control (p < 0.05) but were not significantly different among control and 10 nM-treated
cultures (p > 0.05, Figure 4-3B,C).
The maximum number of APs fired during stimulation while holding the membrane
potential at -70 mV was calculated for each condition. No significant differences were
observed between control and 10 nM treated cultures (p > 0.05); however, 5 µM Aβtreated cultures were significantly lower than all other conditions (p < 0.007, Figure 43D). Despite this difference, AP amplitudes were not significantly different between any
condition tested (p = 0.410, Figure 4-3E). However, while AP amplitude was unaffected
Aβ-treatment, AP waveforms were affected in 5 µM Aβ-treated cultures as rise time and
calculated FWHM values were significantly increased over control and 10 nM treated
cultures (p < 0.05).
Spontaneous APs were recorded from patch-clamped cells with a gap-free protocol
where current was held between -35 and -40 mV (Figure 4-3H). Again, 5 µM Aβ-treated
cultures were significantly hindered in function (p < 0.001). Similarly, chronic 10 nM
treatment was significantly lower than control and 10 nM acute conditions (p ≤ 0.02),
suggesting impaired functional performance in both 5 µM acute and 10 nM chronic
conditions.
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Immunocytochemical analysis of tau expression levels
Immunostaining and confocal microscopy highlighted the presence of tau protein in
cultured neurons under all examined conditions. Control and Aβ treated cultures were
stained for presence total tau protein as early-stage tauopathies may include not only
hyperphorylated tau but other toxic oligomers [149, 150]. The anti-tau antibody used
detects both phosphorylated and non-phosphorylated tau. Analysis of positive staining
intensity revealed increases in tau accumulation in response to Aβ treatment.
Calculation of statistical differences suggested an upregulation of tau expression in 5
µM treated cultures with a greater than 90% confidence interval (p = 0.057). The slight
increase in positivity observed in 10 nM treated cultures was more modest, and
insufficient to suggest any significant changes in tau expression over the time-frame
investigated.
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Discussion

A

human-based

neuronal

culture

system

incorporating

an

accurate

AD

pathophysiological phenotype would be of considerable value to future drug
development and disease modeling applications. While the availability of patient derived
iPSC models of AD are available [151-153], cell line variability may inhibit the
widespread applicability of conclusions drawn from specific lines. Commercially
available iPSC-derived human cells offer an extremely reproducible alternative for
general screening purposes. Study of Aβ mediated phenotypic responses in cultured
wild type neurons offers a widely available platform for generalized assessment of
neurodegeneration in human tissues. Therapeutic screens and/or mechanistic studies
of AD progression, once tested in a generalized model, could then be advanced to
specific patient iPSC lines for continued personalized evaluation. Previous studies have
typically used acute, high doses of Aβ to model AD effects on cells in vitro. However,
our results indicate that although such treatments induce severe pathological
phenotypes rapidly in cultured human neurons, this method may not best recapitulate
the AD disease state as it occurs in vivo.
As of the submission of this article, we are unaware of any study that has used human
iPSCs to characterize the effect of pathophysiological levels of Aβ in vitro. A previous
study has used human cell sources to investigate the effect of high (non-physiologic)
acute doses on Aβ-induced cytotoxicity and cell cycle induction [154]. However,
assessment of the functional response of these cells to physiologically representative
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levels of Aβ over extended culture periods has not been performed. We therefore
investigated treatment of hiPSC-derived neurons with low-doses of Aβ over extended
time-courses to evaluate the ability for these cells to mimic the in vivo pathophysiology
of early AD progression more closely.
AD patients undergo a slow neurodegenerative process which takes years to manifest
in a detectable phenotype [155]. In the early-stages of AD pathology, patients exhibit
synaptic dysfunction, amyloid beta accumulation in the brain but low concentrations of
Aβ1-42 in the cerebral spinal fluid (CSF), a high tau/p-tau ratio in the CSF, and beginning
stages of cortical/hippocampal diminishment [156, 157]. This alteration in functional
performance precedes significant cell death, which usually only occurs in later stages of
AD progression. Acute high doses of Aβ in vitro therefore jump straight to late-stage AD
modeling and do little to accurately recapitulate the slow progressive nature of the
condition. A model system that more closely mimics the mild cognitive impairment stage
of the disease would therefore be more suitable for studies into early AD
pathophysiology. Furthermore, such a system would be beneficial for screening
compounds for their capacity to prevent disease progression before late-stage cell
death occurs.
Our results more closely mirror the in vivo effects of Aβ in human neural tissue at early
stages of AD progression. The collected data highlight that chronic treatment of Aβ at a
physiologic dose results in impaired neuronal firing capacities without significant cell
death. Acute, high dose Aβ treatment also produced a reduction in spontaneous activity,
but this was coupled with a significant reduction in cell viability, indicating a more rapid
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progress toward cell death than is typically seen in AD patients. No significant
differences were seen in AP amplitudes when under current clamp, indicating treated
cells were capable of firing APs as healthy control cells but only when membrane
potentials were artificially maintained. AP waveforms were unaltered by chronic or acute
10 nM treatment, but AP rise time and FWHM were significantly increased when acutely
treated with a high dose of Aβ. These results are supported by previous studies which
demonstrate

how

different

Aβ

doses

result

in

significant

and

conflicting

electrophysiological responses in cultured rodent neurons [158, 159]. Furthermore,
changes in AP rise time and FWHM in acute high dose Aβ treated cells indicates a
change in sodium conductance and rectifying potassium channel activity in this
condition [102]. Such drastic functional changes are poorly representative of AD
phenotypes. A recent in vivo study examining cortical and thalmic electrophysiology in a
rat model of AD demonstrated that the disease state produced a significant reduction in
neural activity without alterations in AP waveform metrics [160]. Our presented data
correlate with the findings of this study, and support the hypothesis that chronic low
dose Aβ treatment produces functional phenotypes in cultured human neurons that
more closely recapitulate AD pathology. Furthermore, these findings confirm that acute
high dose Aβ treatment induces functional phenotypic changes in cultured neurons that
are not observed in in vivo models of AD.
While we cannot entirely rule out that the functional deficits seen in chronically-treated
Aβ cultures were due to the prepared low-weight oligomers and not aggregated forms
derived from the added peptide, it is highly unlikely since such higher-weight oligomers,
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if formed, would cause the observed effects as aggregated forms of Aβ have not been
shown to be neurotoxic [123-129]. Furthermore, regular medium changes would reduce
the presence of any aggregated species and maintain a consistent physiological level of
Aβ.
Tau is a major structural protein in neurons responsible for stabilizing axonal
microtubules, and has been shown to be constitutively expressed in iCell neurons
specifically [149]. Neurodegenerative tauopathies, concomitant with AD, include a
reduced association of tau with microtubules, the accumulation of intracellular bundles
of highly insoluble, straight or paired helical tau filaments, and the hyperphosphorylation
of tau and the subsequent formation of neurofibrillary tangles (NFTs) [150]. Moreover, in
stages leading up to (and during) the appearance of NFTs, neurotoxic tau oligomers are
present and have been shown to contribute to neurodegeneration in drosophila and
transgenic mice models of AD [28-31]. As such, the increased presence of tau
aggregates in cells is an established hall mark of neuronal degeneration in AD and
associated tauopathies.
In this study, immunocytochemical analysis of tau protein in cultured cells showed a
significant increase in tau positivity in response to acute high doses of Aβ. Conversely,
neither acute, nor chronic 10 nM Aβ treatments produced significant increases of tau
protein

positivity.

This

result

was

expected

as

Aβ-mediated

impairment

of

electrophysiological function is known to precede accumulation of tau in the brain during
early AD progression. These data provide further evidence to support the hypothesis
that chronic low-dose Aβ is more appropriate for modeling early AD stages in vitro.
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Previous studies have demonstrated that increased presence of Aβ does not upregulate
tau gene expression, but rather promotes the formation of larger tau aggregates through
hyperphosphorylation of specific sites. Given this, the observed increase in tau staining
positivity detected in these experiments is believed to result from increased aggregation
of the protein within cultured cells, thereby increasing the detection of the positive
fluorescence signal above background levels.
Taken together these results suggest that acute, non-physiological doses of Aβ poorly
represent early AD phenotype, in terms of modeling electrophysiological function, cell
death, and tau aggregation. Chronic, physiological levels of Aβ more accurately
recreate the mild functional impairment of neurons during initial neurodegenerative
stages of AD. The stability of these commercial hiPSC-derived neurons over extended
time courses, and the more accurate representation of disease phenotype, demonstrate
the utility of the described system for modeling early AD progression in vitro. As such,
this system is highly amenable to studies designed to further our understanding of AD
progression and provide a valuable potential tool for therapeutic drug screening.
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Figure 4-1. Treatment of hiPSC derived neurons with physiological doses of Aβ
does not appear to effect gross cell morphology or viability. A) Representative
phase contrast images of hiPSC-derived neurons comparing untreated, chronic, and
acute Aβ treated cells at 30 DIV. Scale = 50 µm. B) Viability of hiPSC-derived neurons
determined by MTT assay at 30 DIV following treatment with Aβ. Acute 5 µM treatment
significantly reduced cell viability (P < 0.05) whereas acute and chronic 10 nM
treatments had no significant effect on cell survival.
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Figure 4-2. Representative electrophysiological recordings of untreated and Aβtreated hiPSC-derived neurons. Patch-clamp recordings were taken between 28-30
DIV in control (column A), 10 nM chronic (column B), and 5 µM acute (column C).
Recordings from cells acutely treated with 10 nM Aβ were also taken but are
represented by control data here as there were no significant differences between the
two conditions (p > 0.05). (Top row) Voltage-clamp recording of inward sodium and
outward potassium currents (-70 mV holding potential, 10 mV steps). (Second row)
Neurons fired repeatedly in response to depolarizing current injections at a -70 mV
holding potential. (Third row) A single AP was generated using a 3 ms depolarizing
current pulse of 1-2 nA. (Bottom row) Gap free recordings were performed for up to 5 m
to measure spontaneous activity of patched cells. (Inset) Phase contrast image of
patched neuron. Scale = 20 µM.
80
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Figure 4-3. Changes in electrophysiological characteristics of hiPSC-derived
neurons treated with Aβ. The resting membrane potential (A), peak inward current (B),
peak outward current (C), maximum APs fired in response to depolarizing current
injections at -70 mV (D), and peak action AP (E) are represented at 28 DIV. Whereas
the resting membrane potential, membrane resistance, peak outward current, and AP
amplitude was maintained across all conditions, inward sodium currents and maximum
APs fired were significantly reduced in acute, 5 µM treated cultures (p < 0.05).
Treatment with 5 µM of Aβ resulted in an even more significant drop in spontaneous
neural firing activity (p < 0.01). Time to peak AP and AP duration, and represented by
rise time (F) and FWHM (G) respectively was significantly increased in 5 µM treatment
of Aβ (p < 0.05). 10 nM Aβ acute treatment did not have a significant effect on
spontaneous APs fired during gap-free recordings (H) but chronic 10 nM Aβ resulted in
a significant drop in the spontaneous activity of these cultures (p < 0.05). Error bars
represent SEM.

Figure 4-4. Tau protein is upregulated in hiPSC-derived neurons treated with
higher-than-physiologic concentrations of Aβ. (A) Cells were fixed at culture
endpoints (28-30 DIV) and stained for beta-III tubulin (red), tau (green), and DAPI
(blue). Scale bar = 20 µm. (B) Image analysis of tau protein intensity was analyzed
relative to control tau positive staining while accounting for differences in cell viability (p
= 0.057).
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Table 4-1. HSL1 medium, detailed below, was designed to promote the long-term
survival and maturation of hippocampal neurons in vitro.
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Supplemental Figure 4-5. XPS analysis of laminin on glass vs. laminin on DETA.
XPS analysis of laminin on DETA-modified glass and unmodified glass. The carbonyl
peak, which is indicative of protein for these samples, is smaller on glass than on
DETA-modified glass relative to the underlying substrate (Si).
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Supplemental Figure 4-6. Amyloid beta oligomerization gel electrophoresis and
coomassie blue stain. Pure oligomerized samples of Aβ were run on 10-20% tristricine gels and stained to visualize protein bands. Only low molecular weight bands
were present.
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CHAPTER 5 – FEED-FORWARD NETWORK PATTERNING OF HUMAN
IPSC-DERIVED NEURONS; TOWARDS THE DEVELOPMENT OF A
LAYERED MODEL OF THE HUMAN CORTEX
Introduction

Translation of drug effects from animal trials to clinical research is often poor, with
clinical trials failing in humans after promising results are obtained in animal models
[161]. Inaccurate predictions of therapeutic effects in humans during current animalbased drug testing necessitates the development of robust, human-based in vitro test
beds to improve pre-clinical predictive power. To this end, we are working to model the
central nervous system’s in vivo structure by recapitulating a layered neuronal network
using chemical surface patterns to control cell adhesion.
Dynamic changes in synaptic strength are continuously occurring in vivo with
neurodegeneration occurring when this process breaks down. Cultures maintained on
patterned substrates were stimulated using defined electrical protocols in order to
induce changes in synaptic strength and thereby produce in vitro analogues of
phenomena such as long-term potentiation (LTP). Inhibition of LTP is an indicator of
serious neurodegenerative diseases, such as Alzheimer’s. Current in vitro models of
LTP are limited to slice cultures from animal tissue sources. This study focuses on the
development of a human system whereby LTP can be induced, maintained and altered,
with and without drug treatment, as an indicator of network health and viability.
The ability to generate accurate models of ordered mammalian neural tissue has
remained limited due to the inherent complexity of the native tissue. To date, ordered
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models of the mammalian cortex are few in number, and their capacity to recapitulate
the native layered structure is extremely limited. Several groups have demonstrated that
ordered neural networks could be established at the single cell level using patterned
silane surfaces to control cell adhesion and neuritic development [57, 83, 162].
However, these studies used rodent cells and relied on patch-clamp electrophysiology
for functional assessment, limiting their utility for human-based, high throughput
applications.
More recently, Tang-Schomer et al. generated a 3D neuronal rat model which utilized a
layered silk protein-based porous scaffold and gel matrix to recapitulate components of
in vivo structure and function [163]. However, the presented model was not amenable to
high-throughput drug testing or assessment of network circuitry, since functional
analysis again relied on patch-clamp electrophysiology.
In 2013, Odawara and colleagues demonstrated an ability to generate a 3-layer
neuronal culture system with extensive neuritic growth between the separated cell
populations [28]. Using this system, the authors demonstrated that cells grown within
gravity oriented collagen matrices generated field potential burst firing behavior that was
detectable using a mixture of MEA and calcium imaging analysis. The system was
validated as a means to perform drug analysis through assessment of responses to the
GABA inhibitor bicuculline and AMPA/kainite receptor antagonist CNQX. Despite this
positive data, the model was predominantly validated using rodent cells and only a
preliminary assessment of cell survival was performed with human cell types. Moreover,
although capable of promoting anisotropic neuritic development, the presented model
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was not capable of controlling the direction of this outgrowth (i.e. neurites extended in
both directions along a single axis). As such, the ability of this platform to emulate the
controlled “feed-forward” networks observed in the hippocampus (dentate gyrus to CA3
to CA1) was limited.
Truly predictive preclinical neuropharmacological studies require long-term, highthroughput investigation in real time, but such analysis is nearly impossible with
traditional electrophysiological recording tools. Patch clamp electrophysiology is
invasive, usually limited to single cell measurements, and constrained to short-term
experiments. Experiments conducted using patch-clamp electrophysiology also requires
multiple experimental repeats as coverslips patched are removed from sterile culture
environments. Slice cultures are also for short-term use only and cannot be used for
long-term, chronic study which is required for measuring network activity and slice
culture acquisition required termination perform electrophysiological studies because
they can be used to non-invasively detect network-wide synaptic activity and neural
connectivity of populations long-term. MEAs are also highly accessible to manipulation,
both electrically and environmentally, with the addition of drugs into the media where
effects can be measured across entire networks. Use of MEAs comprised of optically
transparent materials allows for the application of various imaging techniques.
Therefore, MEAs present an excellent tool for building a platform to measure long-term
network activity and synaptic architecture in vitro including the acquisition of synaptic
activity and neural connectivity of individual or populations of neurons in dissociated or
patterned cultures.
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Chemical patterning of cytophilic and cytophobic SAMs facilitated the establishment of
patterned surfaces for the control of cell attachment and neuritic outgrowth [63, 83, 85].
Using this technology, surfaces were patterned to produce neural populations arranged
into layers feeding forward to subsequent layers, thereby mimicking the cellular
architecture of the in vivo tissue. Microelectrode arrays were used to monitor these
layered networks for evidence of network connectivity over time. Previous work has
characterized the initial establishment of this system, and validated the methodology
employed to achieve a functional in vitro analogue of the layered neural networks
observed in the in vivo central nervous system using rat cells [97]. Following the
characterization of an appropriate human-based cell source on a controlled, selfassembled monolayer (SAM) surface that can be used to pattern culture substrates
(Chapter 2), we aim to reproduce the patterned architecture and take the system a step
further by using it to study network responses in reaction to both electrical and chemical
stimuli. With the development of an in vitro system which can predict clinical drug
effects, we hope to improve future medical research and drug development.
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Materials and Methods

Human iPSC culture
Human iPSC-derived neurons were obtained from Cellular Dynamics International (iCell
Neurons, NRC-100-010-001) and plated according to manufacturer’s instructions. Cells
were plated in maintenance medium (NRM-100-121-001 with NRM-100-031-001) and
incubated overnight at 37°C 5% CO2 before medium was changed to Hybrid Systems
Laboratory Medium 1 (HSL1) and half the medium was changed every 3-5 days.
Astrocyte cultures
Commerically available, human astrocytes were obtained from Lonza (Normal Human
Astrocytes, CC-2565) and cultured according to manufacturer’s instructions. Astrocytes
were also derived from rat pups using a protocol adapted from a previously described
method [164]. Briefly, cerebral hemispheres were removed and rinsed with ice-cold
Hibernate E (Gibco, A12476-01) Harvested cortex was then cut into smaller sections
with scalpels and then transferred to Hibernate E without Ca 2+ (BrainBits, HE-CA) with
papain (2 mg/ml) and incubated at 35°C for 10 minutes with shaking. Cells were rinsed
with fresh Hibernate E and mechanically dissociated using a fire-polished Pasteur
pipette before plating in culture-ready flasks. Medium was changed after 2 DIV and
every other day thereafter. After 7-9 DIV, medium was changed, flasks were closed,
and then placed on a rotary shaker at 200 rpm with a 1.5-in. stroke diameter at 37°C for
6 h. Culture medium was discarded and then shaken for another 18 h. After 18 h,
medium was changed again and flasks were again shaken until fewer than 10 phase-
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dark cells per 100x field of view were observed. This method will remove
oligodendrocytes and microglia and leave a nearly pure bed of astrocytes adhered to
the surface of the culture flask. Purified astrocytes were dislodged from the culture
flasks by incubating at 37°C with trypsin (0.05% trypsin/ EDTA in HBSS, Gibco, 25200).
Trypsin inhibitor (trypsin inhibitor, soybean, Gibco, 17075-029) was added at 0.5 mg/ml
to deactivate the trypsin once cells were lifting off the substrate. Suspended cells were
collected and spun at 500 x g for 5 min and then resuspended in fresh culture medium
for plating. Astrocytes were co-cultured with hiPSCs at a ratio of approximately 117
neurons per astrocyte as described previously [165].
Surface preparation
Microelectrode arrays were plasma cleaned for 10 minutes to avoid damage produced
during an acid wash. The method used for surface modification was similar to those
described previously [166, 167]. Briefly, cleaned glass slips and MEAs were immersed
in a 0.1% (v/v) DETA in HPLC-graded or distilled toluene solvent, heated to just below
boiling for 30 minutes, and then allowed to cool to room temperature. The surfaces were
rinsed in fresh toluene, heated for 30 min as before, and oven dried for 2 hrs to
overnight. Patterning was produced via photolithography by exposing the previously
prepared DETA monolayer to 45 seconds of ArF laser irradiation (deep UV 193 nm
excimer laser from Lambda Physik at a pulse power of 230 mW and a frequency of 10
Hz) through a quartz mask (Bandwidth foundry, Eveleigh, Australia). The ablated region
was backfilled with 0.1% tridecafluoro-1,1,2,2-tetrahydrooctyl-1-trichlorosilane (13F) in a
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chloroform solution for 5 min, then rinsed in chloroform, and finally oven dried for 15
min.
For quality control, chemically altered surfaces were measured using a Thermo
ESCALAB 220i-XL X-Ray photoelectron spectroscopy instrument (XPS) equipped with
an aluminum anode and a quartz monochromator. Surface charge compensation was
achieved using a low-energy electron flood gun when necessary. Survey and highresolution scans were recorded for relevant elements on surfaces including Si 2p, C 1s,
N 1s, and O 1s (pass energy of 50 eV, step size = 1 eV). The spectrometer was
calibrated against the reference binding energies of clean Cu, Ag and Au samples.
Peak fitting was performed with Avantage version 3.25 software, provided by Thermo
Electron Corporation. In addition, the binding energy (BE) scale was adjusted such that
the aliphatic C1s peak appears at 285eV. For surface hydrophobicity/hydrophilicity
characterization, a droplet of deionized water (5 µL) was applied to a surface at three
different locations and the average contact angle was taken.
Extracellular MEA recordings
MEAs were obtained from Multichannel systems and consisted of an 8x8 grid of 30 µm
electrodes spaced 200 µm apart. Data was acquired via the Multichannel Systems
1060B amplifier (Sampling rate, 25 kHz, Bandwidth 8 Hz to 10 kHz) with temperature
control set to 37°C. Raw signals were first filtered with a 2nd order Butterworth 300 Hz
high-pass filter followed by spike detection over 5 standard deviations of noise.
Spontaneous neural activity was checked every other day for five minutes during each
experimental session.
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Electrical induction of LTP was initiated by applying tetanic stimulus using protocols
adapted from Chippalone et al. (2008) [168] and Jimbo et al. (1999) [169]. Any active
channels were first probed for their connectivity by applying a biphasic, rectangular
pulse (25 ms at 200 mV followed by 25 ms at -200 mV). A tetanus pulse was then
applied (20 bursts at 0.2 Hz each with 11 pulses at an intraburst frequency of 20 Hz) to
induce LTP followed by probing as before to compare responses pre- and post- tetanus.
PDMS Microtunnels
Mixed PDMS (SYLGARD 184 silicone elastomer kit, Dow Corning) was slowly poured
over a wafer with a SU-8 microtunnel mold and allowed to spread over the whole wafer.
The wafer was then moved to an oven for curing (at least 2 h at 70 ◦C). The cured
PDMS microtunnels were carefully cut from the wafer and sterilized before placement
onto MEAs.
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Results

The design shown in Figure 5-1, based off of previous successful rat neural network
establishment [97], consists of a series of four 100 µm-thick lines that were aligned over
the MEA electrode grid. These lines act as reservoirs for cellular adhesion and growth.
The feed-forward pattern was designed to encourage axonal extension in one direction
by utilizing a broad exit from the cell reservoirs to encourage axonal growth, thin lines
(2.5 µm) of extension which inhibit cell-body adherence, and a fragmented connection
(20 µm gap) leading to succeeding reservoirs which inhibit axons from extending back
(feed-back) along the unidirectionally-designed track (see Figure 5-1) [170]. During
initial cell culture phase (0 to ~4 DIV), cells which land outside the patterned reservoirs
will either migrate toward the DETA patterned surface (if they are within a short radius)
or, being unable to successfully adhere to the culture surface, will eventually die.
Initial pattern adherence tests were done to narrow down an optimal plating density for
MEAs. Human iPSCs were plated at 500, 700, and 1000 cells/mm2 on glass coverslips
and monitored over the first 4 DIV. Human iPSCs were able to successfully respond to
the patterned chemical cues and migrate to the DETA-patterned surfaces over 4 DIV for
all densities plated without overwhelming the pattern (Figure 5-2). Likewise, cells were
able to successfully conform to the pattern when grown on aligned MEAs (Figure 5-3).
Following the results from this initial pattern test, hiPSCs were plated onto patterned
MEAs at 500, 1000, and 2000 cells/mm2 to evaluate electrical function at various
densities. hiPSCs cultured on both patterned and unpatterns MEAs were checked daily
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for activity but either no or sporadic activity on no more than one channel at a time was
detected for over 30 DIV.
According to Cellular Dynamics International (CDI), the hiPSCs consisted of a mixed
population of GABAergic and glutamatergic neurons at proportions of approximately 60
% and 40 % respectively. We hypothesized that the inhibitory, GABAergic neurons may
be dampening the signal of the excitatory, glutamatergic neurons. In order to increase
the

spontaneous

activity

of

the

hiPSCs,

various

combinations

of

neurotransmitters/blockers were added to boost electrophysiological maturation of the
cultures. Previously, it has been shown that addition of 25 µM of glutamate stimulates
recovery of electrical function in cultured adult rat hippocampal neurons with little
toxicity [61]. In addition, augmentation of cultures with 0.08, 0.4, 2, 10, 50 µM GABAzine
(Sigma, SR-95531) has been shown to increase spontaneous activity on MEAs (CDI,
http://www.cellulardynamics.com/products/neurons.html). Cultures plated at 500, 850,
or 1000 cells/mm2 onto MEAs (patterned and unpatterned) and were chronically grown
either without any additional compounds or in medium containing 25 µM glutamate, 0.4
µM GABAzine, 25 µM glutamate and 0.4 µM GABAzine, 25 µM glutamate and 20 µM
GABAzine, or 25 µM glutamate and 40 µM GABAzine. Cultures grown on MEAs without
additional drugs were also acutely treated with increasing concentrations of both
glutamate and GABAzine to try to induce electrical activity. No consistent, robust activity
was seen on any condition tested. While almost all MEAs had no spontaneous activity,
a few displayed spontaneous activity on one channel (out of 63). In order to stimulate
electrical activity, these MEAs with active channels were stimulated using a tetanic
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pulse. Post stimulation these channels either decreased in activity or did not change
their spontaneous firing.
In order to support network formation and increase spontaneous activity of hiPSCs,
astrocytes were co-cultured with hiPSCs. Unpatterned, DETA-coated MEAs were
treated with laminin following positive results described in Chapter 2 of this dissertation.
When co-cultured with hiPSCs, Normal Human Astrocytes (NHA) caused massive
clumping of neurons resulting in peeling and eventual cell death. All of the MEAs
cultured with the NHA had peeled off within three weeks with no detected electrical
activity. Following the unsuccessful culture of NHA with hiPSCs, hiPSCs were cocultured with purified glia derived from primary rat pups. Primary rat glia had previously
been shown to increase the spontaneous activity of the hiPSCs utilized for this study
[165]. Additionally, cells were cultured with microtunnels (Figure 5-4) as previously
described [171, 172] in a collaboration with Bruce Wheeler’s lab. Tunnels were placed
in the center of the MEA field, essentially bisecting the electrode area in half. To induce
feed-forward architecture, PDMS barriers were placed at one side of the microtunnels
for ~3 DIV to allow axonal extension through the microtunnels from only one side. Upon
removal, neuritic extensions were observed reaching between the previously separated
cell populations. Neurons were able to successfully extend processes through these
microtunnels as activity was consistently detected within the microtunnels; however,
activity was never detected outside the tunnels. Test pulses (200 mV biphasic square
pulse) were performed on active channels within the tunnels of each MEA but no
responses were observed in adjacent channels just outside the tunnels. The same
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results were observed for MEAs cultures in which no barrier was placed to block entry
from one side of the microtunnels.
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Discussion

The development of a system that more closely recapitulates or mimics in vivo neural
architecture would be a useful tool for basic science research and/or high-throughput
screening of therapeutic compounds. To this end, we attempted to culture hiPSCs on
MEAs that were patterned in a feed-forward manner to provide a layer of control over
the cultured neural networks. Results indicate these hiPSCs are able to grow robustly
and respond to chemical surface patterning cues (Figures 5-2, 5-3). Previous studies
utilizing patch-clamp electrophysiology have shown that these cells are electrically
active and functionally mature (Chapters 2,3) [81, 173]. However, consistent, robust
activity was not detected with or without patterns when plated at multiple cell densities
(from 500 to 2000 cells/mm2), with glutamate addition (25 µM), by addition of various
concentrations of GABAzine (0.4 to 40 µM) with or without the presence of glutamate, in
response to electrical stimuli, or when co-cultured with NHA. Signals were only detected
when amplified by the increased resistance of the microtunnels in the presence of
supportive purified rat glia.
Signal detection on MEAs is mediated by a tight cell-electrode attachment, sufficient
field potential amplitude, and electrophysiological competency of cultured cells.
Consequently, an inability to detect signals suggests a failure of one of these
parameters. A lack of electrophysiological competency of these hiPSCs is unlikely given
the successful detection of spontaneous activity of these cells previously via patchclamp. As such, issues with cell attachment or field potential amplitude seem more
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likely. Field potential amplitude is affected by cell density and cell maturity. Again,
previous patch-clamp data suggests cell maturity is not likely to be a factor in the
cultured conditions. The manufacturer’s suggested plating protocol for MEAs
recommended significantly higher cell densities in small volumes in order to obtain
robust field potential recordings. Our plating protocols were limited to lower cell
densities as higher densities would overwhelm the surface pattern and result in poor
pattern fidelity. However, this disparity in plating procedures may explain the lack of
reliably observed activity in maintained cultures. Expanded cell density ranges were
being investigated with the inclusion of microtunnels that allowed higher plating
densities while still providing a feed-forward architecture.
Human iPSCs cultured on MEAs consistently appeared qualitatively poorer in cell health
compared to patterned or unpatterned glass coverslip controls. As such, the MEA
substrate

may

constitute

a

less

amenable

environment

for

promoting

the

electrophysiological development of these cells. Investigation into alternative MEA
platforms may be a viable direction for future research. High-throughput platforms are
available from multiple vendors, e.g. Axion Biosystems, and MED64. However, these
platforms may not be amenable to photolithography patterning methods due to surface
material composition or physical obstruction of the photo mask necessary for surface
ablation by built-in culture wells. In these cases, micro-contact printing of laminin or
other surface molecules may be utilized.
Alternatively, use of MEAs could be substituted for another method of signal detection.
Detection of AP firing can be achieved via a rapid-response voltage-sensitive protein
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probe such as ArcLight [174]. Optical signals can be used to non-invasively map action
potential propagation in response to drug treatment or external electrical stimulation.
This stimulation could come from microelectrodes or by using optogentically engineered
neurons which could be stimulated via laser pulse for point stimulation or LED arrays for
multisite stimulation [175]. Directed propagation of APs across designated neuronal
architecture could easily be visualized utilizing this method. In addition, optical detection
has previously used to assess LTP in hippocampal slices [176, 177], suggesting the use
of this method to analyze more complex brain function in vitro is a viable alternative to
using MEAs.
In conclusion, the development of an ordered model of the human CNS remains an
exciting prospect for improving preclinical analysis methods, and a significant
bioengineering challenge. The potential uses for such an in-vitro test bed include
investigation into neurodegenerative disease, traumatic brain injury, and stroke.
Movement toward using a high-throughput in vitro system would expand and improve
drug testing and basic research capabilities by providing a viable, easily manipulatable
alternative to expensive, resource intensive in vivo testing. Such a platform would also
make drug testing and disease research easier and faster, leading to the more rapid
development of drug therapies. However, our work described here and the work of
others [28, 57, 83, 162, 163], highlights that further development is needed to enable
the reliable generation of biomimetic high throughput neuronal cultures for such
applications.
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Figure 5-1. Schematic of feed-forward chemical pattern architecture for MEAs.
Purple areas correspond to areas with cell-attracting chemical treatment. Small blue
dotted background corresponds to chemically treated areas which are not favorable for
cell growth. Grey circles indicate positions of microelectrodes (not to scale and not part
of pattern). Reservoirs for cellular attachment are 100 µm tall and span the length of the
entire microelectrode area. Axonal tracts (thin connecting lines, 2.5 µm wide) direct
axonal growth in the indicated direction and extend to within 20 µm of the connecting
reservoir where there are breaks to prevent backward axonal growth.

Figure 5-2. Time-lapse phase-contrast images of hiPSCs grown on DETA/13F
feed-forward patterns on glass coverslips. Human iPSCs were plated at 1000
cells/mm2 onto patterned glass coverslips and monitored over 4 DIV for pattern
adherence. Scale = 50 µm.
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Figure 5-3. Successful patterning of hiPSCs arranged over a MEA at 7 DIV. Cells
were plated onto DETA/13F feed-forward patterned MEAs where they exhibited
accurate pattern conformity. Scale = 200 µm.
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Figure 5-4. PDMS microtunnels on MEAs. Cells were plated on either side of µm by 3
µm microtunnels that bisected the field of electrodes and created two separate culture
populations. PDMS barriers (not shown) were also placed on one side of the
microtunnels on for some cultures to allow one cell population to extend axons to
synapse on the other side for unidirectional flow of APs from one population to the
other. Scale = 100 µm.
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CHAPTER 6 – GENERAL DISCUSSION

Current efforts to build more advanced, biomimetic in vitro test beds are limited by the
availability of an appropriate cell sources, the ability to accurately recapitulate in vivo
disease states, and the capacity to engineer microenvironments capable of supporting
complex tissue architecture and interactions between cell types.
The selection of an appropriate cell source is vital to gaining accurate predictions of in
vivo responses. Chapter 2 described significant differences between embryonic and
adult rat phenotypes, highlighting the importance of achieving mature endpoints for
effective drug screening and disease modeling. The reported findings are of significance
given the historical importance of rodent cells for in vitro testing, and the continued
reliance of investigators on such models for many basic science and applied
applications today. Indeed, animal models continue to serve as a standard test system
for pre-clinical screening of novel drug compounds. However, the generation of iPSCs
offers new possibilities in human tissue modeling and holds the potential for the
development of a new standard in pre-clinical drug assessment. As these human cell
sources become more readily available, proper vetting across multiple research groups
is required to adequately define maturation endpoints and identify suitable time-points
for consistent compound evaluation. Chapter 3 highlighted the suitability of one-such
commercially-available human neuronal iPSC-derived cell source. These pure
populations of neuronal cells displayed typical morphology, expressed correct neuronal
markers, were mitotically stable, and could robustly fire APs for over a month in culture.
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These cells were also able to thrive on and respond to chemically patterned surfaces,
as described in further detail in Chapter 5. Taken together, these results indicate that
these commercial hiPSC-derived neurons are suitable candidates for extended in vitro
studies, and can be applied to chemically-engineered substrates similar to those used in
drug-screening platforms [78, 178]. The demonstrated long-term stability of these
neuronal cultures also makes assessment of disease progression over longer periods
more feasible. Chapter 4 demonstrated the capacity for these cells to be used as a
model for early AD progression, whereby physiological, chronic doses of Aβ produced
electrophysiological responses in hiPSC-derived neurons similar to those observed in
the neuronal tissue of AD patients in vivo [155, 179]. Improvement of current preclinical
screening paradigms necessitates the development of models that more closely
recapitulate the physiological traits of human diseases. The ability for the developed
culture protocol to more closely model AD disease progression therefore represents an
important step towards the establishment of more predictive disease models, both for
mechanistic studies of pathophysiology and as testbeds for the development of novel
therapeutics.
The establishment of a reliable and robust human cell source, with the capacity to
recapitulate mature phenotypic behavior and functional responses to Aβ treatment, will
be of considerable value to investigators seeking to model AD progression. However,
accurate predictions of neural tissue responses are predicated on the development of
more complex and biomimetic neural culture platforms capable of accurately
recapitulating CNS behavior. In Chapter 5 we attempted to build a layered, feed-forward
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neuronal architecture over MEAs in order to establish a defined network for evaluation
of drug responses and/or study of synaptic mechanisms. Human iPSC-derived neurons
were able to adhere to and follow chemically patterned cues with high fidelity. However,
due to challenges in obtaining spontaneous network activity of the cultured cells on
MEAs, we were unable to reproduce results similar to those seen previously using
embryonic rat hippocampal neurons using this method [97]. In order to improve the
spontaneous activity of cultures, alterations in cell density, surface treatment, medium
composition, addition of glutamate and/or GABAzine, and supporting astrocytes from
multiple sources were applied. Despite these extensive efforts, spontaneous activity
was still rarely detected. Interestingly, when neurons were cultured on MEAs in two
small wells divided by a series of microtunnels, robust activity was detected within the
microtunnels but never in the wells where the cell bodies were adhered. This result
verifies the functionality of the MEAs used, and indicates that analysis of neuronal
activity using these cells on MEAs should be possible within a fully-optimized system. It
may be that these cultures require maintenance within an enclosed platform (e.g. a
microfluidic model) to prevent dissipation of field potential signals and enhanced data
capture from underlying electrodes. The integration of an enclosed culture model with
MEAs is therefore a viable option for future platform development. Such a model would
be in keeping with current efforts towards the development of organ-on-a-chip systems
and eventual establishment of multi-organ body-on-a-chip platforms for systemic toxicity
screening [8, 77].
In conclusion, the major findings of this thesis are:
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1. Embryonic rat neurons take 3-4 weeks in culture to develop a mature profile of AMPA
and NMDA ion channel subunits. Therefore, this model system is inappropriate for
studying neurodegenerative diseases until the underdeveloped neurons have fully
matured in culture.
2. Adult rat neurons have a more advanced ion channel expression profile than
embryonic-sourced tissue corresponding with the synaptic machinery implicated in
neurodegenerative disease. Adult cultures may therefore serve as a better-suited model
for studying complex, advanced-age diseases than embryonic rat cultures.
3. Commercially-sourced human iPSC-derived neurons possess similar characteristics
to their in vivo counterparts as they display typical neuronal morphology, remain
mitotically stable and differentiated for extended periods, express deep-layer marker
CTIP2, and are capable of robust electrical function including repetitively firing action
potentials. Moreover, their ability to respond to chemical cues makes them an ideal
candidate for in vitro modeling of complex neural architecture for body-on-a-chip
applications.
4. Early AD progression can be modeled in vitro using chronic, low-dose treatments of
Aβ, which more closely mimics the in vivo effects of Aβ in human neural tissue at
primary stages of AD. Chronic treatment of Aβ at a physiologic dose results in impaired
neuronal firing capacities without significant cell death, as seen in vivo.
5. Acute, high dose Aβ treatment produces a reduction in spontaneous activity, but this
is coupled with a significant reduction in cell viability, indicating a more rapid progress
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toward cell death than is typically seen in AD patients. Acute, high-dose Aβ treatments
are therefore an inappropriate model of AD.
6. While we were unable to fully-validate the proposed ordered CNS model, despite
extensive optimization experiments, the collection of robust firing activity within
microtunnels supports the development of spontaneous network activity within these
patterned cultures. As such, the proposed platform remains a viable strategy for
continued development towards the establishment of a biomimetic model of the human
cortex.
Successful development of complex in vitro models of the human CNS, employing cell
culture protocols developed during this thesis could enable more accurate and
predictive drug screening and disease modeling to improve patient well-being and
recovery. In order to carry this work forward, future studies should focus on integration
of these functional human neurons with bioengineered platforms capable of recreating
human neural architectures in vitro. In doing so, investigators will improve the biological
relevance of these culture systems and enhance their capacity to predict human neural
responses to drug treatment or pathological challenge. In addition, the capacity to
assess neuronal performance in situ will facilitate real-time analysis of cellular
development and maturation within these models. Such functionality will greatly improve
the overall utility of these models as they will enable continuous assessment of cellular
function and maturation rather than the limited perspective obtained via end-point
analysis.
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Once such integrated platforms are established, continued drive towards more
biomimetic tissue culture models for improved in vitro modeling should include the
integration of supporting cell types, such as astroglia, microglia, and oligodendrocytes,
in biologically representative ratios. Recent efforts with co-culture systems [180, 181]
indicate that successful maintenance of multiple related cell types is feasible and such
complexity is necessary to accurately model human neural tissue in vitro.
Finally, the integration of a biomimetic CNS model with other organ-on-a-chip platforms
would be advantageous towards the establishment of complex, microfluidic body-on-achip systems. Although no-one has yet published more than 4 interconnected organ
microenvironments [181], the development of models recapitulating complete human
systems is an exciting possibility for future preclinical studies and a current focus of
academic, government, and pharmaceutical entities. To that end, investigators seeking
to drive the work in this thesis towards body-on-a-chip relevance must consider that
inclusion of a suitable blood-brain-barrier (BBB) model is essential if one wishes to
accurately model drug, distribution, absorption, and toxicity in neural tissue [182]. As
such, the development of a CNS-BBB co-culture system would be a sensible first step
towards a more complex multi-organ platform.
As stated previously, neurological disorders are gaining increasing prevalence in
developed countries. The need for improved, human models of neural tissue for
accurate and effective disease modeling and drug screening has therefore never been
greater. The work in this thesis encompasses important steps towards improving cell
culture paradigms for more effectively identifying and testing drug targets for new
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potential therapeutics. Continued progress in this direction, utilizing the data presented
herein, will help improve the translation of benchtop results to bedside treatment, and
ultimately improve patient care, wellbeing, and recovery.

110

REFERENCES

[1] SSD W, Design LK. The 2012 Statistical Abstract-US Census Bureau. 2011.
[2] Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. Alzheimer disease in the
us population:

Prevalence

estimates using the

2000

census.

Arch

Neurol.

2003;60:1119-22.
[3] Mangialasche F, Solomon A, Winblad B, Mecocci P, Kivipelto M. Alzheimer's
disease: clinical trials and drug development. The Lancet Neurology. 2010;9:702-16.
[4] DiMasi JA, Grabowski HG. The cost of biopharmaceutical R&D: is biotech different?
Managerial and Decision Economics. 2007;28:469-79.
[5] DiMasi JA, Hansen RW, Grabowski HG. The price of innovation: new estimates of
drug development costs. Journal of Health Economics. 2003;22:151-85.
[6] Vernon JA, Golec JH, Dimasi JA. Drug development costs when financial risk is
measured using the Fama-French three-factor model. Health economics. 2010;19:10025.
[7] Sullivan F. Early Screening, Innovative Solutions to Underline Importance of
ADME/Tox Technologies in Successful Drug Development. In: Sullivan F, editor.
Considerable

Time,

Cost

Savings

to

Accrue

from

Advanced

ADME/Tox

Technologies2005.
[8] Esch MB, Smith A, Prot J-M, Sancho CO, Hickman J, Shuler ML. How Multi-Organ
Microdevices Can Help Foster Drug Development. Advanced drug delivery reviews.
2014;0:158-69.

111

[9] Kola I, Landis J. Can the pharmaceutical industry reduce attrition rates? Nat Rev
Drug Discov. 2004;3:711-6.
[10] McGonigle P, Ruggeri B. Animal models of human disease: challenges in enabling
translation. Biochemical pharmacology. 2014;87:162-71.
[11] Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, et al. Genomic
responses in mouse models poorly mimic human inflammatory diseases. Proceedings
of the National Academy of Sciences. 2013;110:3507-12.
[12] Chang R, Liu X, Li S, Li X-J. Transgenic animal models for study of the
pathogenesis of Huntington’s disease and therapy. Drug design, development and
therapy. 2015;9:2179.
[13] Andersen P. Amyotrophic lateral sclerosis associated with mutations in the CuZn
superoxide dismutase gene. Curr Neurol Neurosci Rep. 2006;6:37-46.
[14] Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al.
Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic
lateral sclerosis. Nature. 1993;362:59-62.
[15] Julien J-P, Kriz J. Transgenic mouse models of amyotrophic lateral sclerosis.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2006;1762:1013-24.
[16] Benatar M. Lost in translation: treatment trials in the SOD1 mouse and in human
ALS. Neurobiol Dis. 2007;26:1-13.
[17] Zhang D, Luo G, Ding X, Lu C. Preclinical experimental models of drug metabolism
and disposition in drug discovery and development. Acta Pharmaceutica Sinica B.
2012;2:549-61.

112

[18] Wan W, Cao L, Kalionis B, Xia S, Tai X. Applications of Induced Pluripotent Stem
Cells in Studying the Neurodegenerative Diseases. Stem cells international.
2015;2015:382530.
[19] Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction
of pluripotent stem cells from adult human fibroblasts by defined factors. Cell.
2007;131:861-72.
[20] Cai J, Li W, Su H, Qin D, Yang J, Zhu F, et al. Generation of human induced
pluripotent stem cells from umbilical cord matrix and amniotic membrane mesenchymal
cells. J Biol Chem. 2010;285:11227-34.
[21] Loh YH, Agarwal S, Park IH, Urbach A, Huo H, Heffner GC, et al. Generation of
induced pluripotent stem cells from human blood. Blood. 2009;113:5476-9.
[22] Xue Y, Cai X, Wang L, Liao B, Zhang H, Shan Y, et al. Generating a nonintegrating human induced pluripotent stem cell bank from urine-derived cells. PLoS
One. 2013;8:e70573.
[23] Zhou T, Benda C, Dunzinger S, Huang Y, Ho JC, Yang J, et al. Generation of
human induced pluripotent stem cells from urine samples. Nat Protoc. 2012;7:2080-9.
[24] Malik N, Rao M. A Review of the Methods for Human iPSC Derivation. In:
Lakshmipathy U, Vemuri MC, editors. Pluripotent Stem Cells: Humana Press; 2013. p.
23-33.
[25] Jang J, Yoo JE, Lee JA, Lee DR, Kim JY, Huh YJ, et al. Disease-specific induced
pluripotent stem cells: a platform for human disease modeling and drug discovery.
Experimental & molecular medicine. 2012;44:202-13.

113

[26] Luo Y, Fan Y, Chen X, Yue L, Yu B, Li Q, et al. Modeling induced pluripotent stem
cells from fibroblasts of Duchenne muscular dystrophy patients. The International
journal of neuroscience. 2014;124:12-21.
[27] Rajamohan D, Matsa E, Kalra S, Crutchley J, Patel A, George V, et al. Current
status of drug screening and disease modelling in human pluripotent stem cells.
Bioessays. 2013;35:281-98.
[28] Odawara A, Gotoh M, Suzuki I. A three-dimensional neuronal culture technique that
controls the direction of neurite elongation and the position of soma to mimic the layered
structure of the brain. RSC Advances. 2013;3:23620-30.
[29] Dennis RG, Dow DE. Excitability of skeletal muscle during development,
denervation, and tissue culture. Tissue engineering. 2007;13:2395-404.
[30] Yang X, Pabon L, Murry CE. Engineering Adolescence: Maturation of Human
Pluripotent Stem Cell–Derived Cardiomyocytes. Circulation Research. 2014;114:51123.
[31] Juhas M, Engelmayr GC, Fontanella AN, Palmer GM, Bursac N. Biomimetic
engineered muscle with capacity for vascular integration and functional maturation in
vivo. Proceedings of the National Academy of Sciences. 2014;111:5508-13.
[32] Holt GR, Softky WR, Koch C, Douglas RJ. Comparison of discharge variability in
vitro and in vivo in cat visual cortex neurons. J Neurophysiol. 1996;75:1806-14.
[33] Williams CS, Watson AJM, Sheng H, Helou R, Shao J, DuBois RN. Celecoxib
Prevents Tumor Growth in Vivo without Toxicity to Normal Gut: Lack of Correlation
between in Vitro and in Vivo Models. Cancer Research. 2000;60:6045-51.

114

[34] Varghese K, Molnar P, Das M, Bhargava N, Lambert S, Kindy M, et al. A new
standard for amyloid Beta toxicity validated by standard and high-throughput
electrophysiology. PLos one. 2010;5:8643.
[35] Chang JC, Brewer GJ, Wheeler BC. Modulation of neural network activity by
patterning. Biosens Bioelectron. 2001;16:527-33.
[36] Golan H, Mikenberg K, Greenberger V, Segal M. GABA withdrawal modifies
network activity in cultured hippocampal neurons. Neural Plasticity. 2000;7:31-42.
[37] Stead J, Neal C, Meng F, Wang Y, Evans S, Vazquez D, et al. Transcriptional
Profiling of the developing rat brain reveals that the most dramatic regional
differentiation in gene expression occurs postpartum. Journal of Neuroscience.
2006;26:345-53.
[38] Kamphuis W, Dijk F, O'Brien B. Gene expression of AMPA-type glutamate receptor
subunits in rod-type ON bipolar cells of rat retina. European Journal of Neuroscience.
2003;18:1085-92.
[39] Monyer H, Burnashev N, Laurie D, Sakmann B, Seeburg P. Developmental and
regional expression in the rat brain and functional properties of four NMDA receptors.
Neuron. 1994;12:529-40.
[40] Brewer L, Thibault O, Stanton J, Thibault V, Rogers J, Garci-Ramos G, et al.
Increased vulnerability of hippocampal neurons with age in culture:

Temporal

association with increases in NMDA receptor current, NR2A subunit expression and
recruitment of L-type calcium channels. Brain Research. 2007;1151:20-31.
[41] Safronov BV, Wolff M, Vogel W. Axonal expression of sodium channels in rat spinal
neurons during postnatal development. Journal of Physiology. 1999;524:729-34.

115

[42] Beckh S, Noda M, Lubbert H, Numa S. Differential regulation of three sodium
channel messenger RNAs in the rat central nervous system during development. The
EMBO Journal. 1989;8:3611-6.
[43] Abe K. Neural activity-dependent regulation of gene expression in developing and
mature neurons. Dev Growth Differ. 2008;50:261-71.
[44] Cheng B, Furukawa K, O'Keefe JA, Goodman Y, Kihiko M, Fabian T, et al. Basic
fibroblast growth factor selectively increases AMPA-receptor subunit GluR1 protein level
and differentially modulates Ca2+ responses to AMPA and NMDA in hippocampal
neurons. J Neurochem. 1995;65:2525-36.
[45] Mattson MP, Kumar KN, Wang H, Cheng B, Michaelis EK. Basic FGF regulates the
expression of a functional 71 kDa NMDA receptor protein that mediates calcium influx
and neurotoxicity in hippocampal neurons. J Neurosci. 1993;13:4575-88.
[46] Gonzalez-Sulser A, Wang J, Motamedi GK, Avoli M, Vicini S, Dzakpasu R. The 4aminopyridine in vitro epilepsy model analyzed with a perforated multi-electrode array.
Neuropharmacology. 2011;60:1142-53.
[47] Wagenaar DA, Madhavan R, Pine J, Potter SM. Controlling bursting in cortical
cultures with closed-loop multi-electrode stimulation. The Journal of Neuroscience.
2005;25:680-8.
[48] Edwards D, Das M, Molnar P, Hickman JJ. Addition of glutamate to serum-free
culture promotes recovery of electrical activity in adult hippocampal neurons in vitro.
Journal of Neuroscience Methods. 2010;190:155-63.
[49] Edwards D, Stancescu M, Lambert S, Hickman J. Derivation of a population of
stable electrically active neurons from the adult rat brain through manipulation of cdk5
activity. Journal of Neuroscience. 2011.
116

[50] Lambert M, Barlow A, Chromy B, Edwards C, Freed R. Diffusible, nonfibrillar
ligands derived from A beta (1-42) are potent ccentral nervous system neurotoxins.
Proceedings of the National Academy of Sciences of the United States of America.
1998;95:6448-53.
[51] Gureviciene I, Ikonen S, Gureviclus K, Sarkaki A, van Groen T. Normal induction
but accelerated decay of LTP in APP+PS1 transgenic mice. Neurobiology of Disease.
2004;15:188-95.
[52] Gross G, Rhoades B, Azzazy H, Wu M. The use of neuronal networks on
multielectrode arrays as biosensors. Biosensors and Bioelectronics. 1995;10:553-67.
[53] Chiappalone M, Vato A, Tedesco M, Marcoli M, Davide F, Martinoia S. Networks of
neurons coupled to microelectrode arrays:

a neuronal sensory system for

pharmacological applications. Biosensors and Bioelectronics. 2003;18:627-34.
[54] Keefer E, Gramowski A, Stenger D, Pancrazio J, Gross G. Characterization of
acute neurotoxic effects of trimethylopropane via neuronal network biosensors.
Biosensors and Bioelectronics. 2001;16.
[55] Hofmann F, Bading H. Long-term recordings with microelectrode arrays: Studies of
transcription-dependent neuronal plasticity and axonal regeneration. Journal of
Physiology-Paris. 2006;99:125-32.
[56] Gross G, Gramowski A, Schiffmann D. Neural network cultures on multielectrode
chips: Self-organization of electrically active networks and their uses in neurotoxicology
and neuropharmacology. European Journal of Cell Biology. 1997;74:36.
[57] Edwards D, Stancescu M, Molnar P, Hickman J. Two cell networks of adult
hippocampal neurons on self-assembled monolayers for the study of neuronal
communication in vitro. Biomaterials. 2011.
117

[58] Marom S, Shahaf G. Development, learning and memory in large random networks
of cortical neurons:

lessons beyond anatomy. Quarterly Reviews of Biophysics.

2002;35:63-87.
[59] Brewer GJ, Torricelli JR, Evege EK, Price PJ. Optimized survival of hippocampal
neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J
Neurosci Res. 1993;35:567-76.
[60] Schaffner AE, Barker JL, Stenger DA, Hickman JJ. Investigation of the factors
necessary for growth of hippocampal neurons in a defined system. Journal of
Neuroscience Methods. 1995;62:111-9.
[61] Edwards D, Das M, Molnar P, Hickman JJ. Addition of glutamate to serum-free
culture promotes recovery of electrical activity in adult hippocampal neurons in vitro.
Journal of Neuroscience Methods. 2010;190:155-63.
[62] Das M, Bhargava N, Gregory C, Riedel L, Molnar P, Hickman JJ. Adult rat spinal
cord culture on an organosilane surface in a novel serum-free medium. In Vitro Cell Dev
Biol Anim. 2005;41:343-8.
[63] Ravenscroft M, Bateman K, Shaffer K, Schessler H, Jung DR, Schneider TW, et al.
Developmental neurobiology implications from fabrication and analysis of hippocampal
neuronal networks on patterned silane- modified surfaces. Journal of American
Chemical Society. 1998;120:12169-77.
[64] Kamioka H, Maeda E, Jimbo Y, Robinson HP, Kawana A. Spontaneous periodic
synchronized bursting during formation of mature patterns of connections in cortical
cultures. Neurosci Lett. 1996;206:109-12.
[65] Opitz T, De Lima AD, Voigt T. Spontaneous Development of Synchronous
Oscillatory Activity During Maturation of Cortical Networks In Vitro2002.
118

[66] Abrous DN, Koehl M, Le Moal M. Adult Neurogenesis: From Precursors to Network
and Physiology. Physiol Rev. 2005;85:523-69.
[67] Liu X, Murray K, Jones E. Switching of NMDA receptor 2A and 2B subunits at
thalamic and cortical synapses during early postnatal development. Journal of
Neuroscience. 2004;24:8885-95.
[68] Alberdi E, Sánchez-Gómez MV, Cavaliere F, Pérez-Samartín A, Zugaza JL, Trullas
R, et al. Amyloid β oligomers induce Ca 2+ dysregulation and neuronal death through
activation of ionotropic glutamate receptors. Cell calcium. 2010;47:264-72.
[69] Texidó L, Martín-Satué M, Alberdi E, Solsona C, Matute C. Amyloid β peptide
oligomers directly activate NMDA receptors. Cell calcium. 2011;49:184-90.
[70] Liu J, Chang L, Roselli F, Almeida OF, Gao X, Wang X, et al. Amyloid-β induces
caspase-dependent loss of PSD-95 and synaptophysin through NMDA receptors.
Journal of Alzheimer's Disease. 2010;22:541-56.
[71] Li S, Jin M, Koeglsperger T, Shepardson NE, Shankar GM, Selkoe DJ. Soluble Aβ
oligomers inhibit long-term potentiation through a mechanism involving excessive
activation of extrasynaptic NR2B-containing NMDA receptors. The Journal of
Neuroscience. 2011;31:6627-38.
[72] Mucke L, Selkoe DJ. Neurotoxicity of Amyloid β-Protein: Synaptic and Network
Dysfunction. Cold Spring Harbor Perspectives in Medicine. 2012;2.
[73] Tang Y-P, Shimizu E, Dube GR, Rampon C, Kerchner GA, Zhuo M, et al. Genetic
enhancement of learning and memory in mice. Nature. 1999;401:63-9.

119

[74] Liu L, Wong TP, Pozza MF, Lingenhoehl K, Wang Y, Sheng M, et al. Role of NMDA
Receptor Subtypes in Governing the Direction of Hippocampal Synaptic Plasticity.
Science. 2004;304:1021-4.
[75] Isaac JTR, Ashby MC, McBain CJ. The Role of the GluR2 Subunit in AMPA
Receptor Function and Synaptic Plasticity. Neuron. 2007;54:859-71.
[76] Kim C-H, Chung HJ, Lee H-K, Huganir RL. Interaction of the AMPA receptor
subunit GluR2/3 with PDZ domains regulates hippocampal long-term depression.
Proceedings of the National Academy of Sciences. 2001;98:11725-30.
[77] Sung JH, Esch MB, Prot J-M, Long CJ, Smith A, Hickman JJ, et al. Microfabricated
mammalian organ systems and their integration into models of whole animals and
humans. Lab on a Chip. 2013;13:1201-12.
[78] Smith AS, Long CJ, Berry BJ, McAleer C, Stancescu M, Molnar P, et al.
Microphysiological systems and low-cost microfluidic platform with analytics. Stem cell
research & therapy. 2013;4 Suppl 1:S9.
[79] Huh D, Torisawa Y-s, Hamilton GA, Kim HJ, Ingber DE. Microengineered
physiological biomimicry: Organs-on-Chips. Lab on a Chip. 2012;12:2156-64.
[80] Ghaemmaghami AM, Hancock MJ, Harrington H, Kaji H, Khademhosseini A.
Biomimetic tissues on a chip for drug discovery. Drug Discovery Today. 2012;17:17381.
[81] Haythornthwaite A, Stoelzle S, Hasler A, Kiss A, Mosbacher J, George M, et al.
Characterizing Human Ion Channels in Induced Pluripotent Stem Cell–Derived
Neurons. Journal of Biomolecular Screening. 2012;17:1264-72.

120

[82] Wilson K, Stancescu M, Das M, Rumsey J, Hickman J. Direct patterning of
coplanar

polyethylene

glycol

alkylsilane

monolayers

by

deep-ultraviolet

photolithography as a general method for high fidelity, long-term cell patterning and
culture. Journal of Vacuum Science &amp; Technology B. 2011;29:-.
[83] Edwards D, Stancescu M, Molnar P, Hickman JJ. Two Cell Circuits of Oriented
Adult Hippocampal Neurons on Self-Assembled Monolayers for Use in the Study of
Neuronal Communication in a Defined System. ACS Chemical Neuroscience.
2013;4:1174-82.
[84] Schaffner AE, Barker JL, Stenger DA, Hickman JJ. Investigation of the factors
necessary for growth of hippocampal neurons in a defined system. Journal of
Neuroscience Methods. 1995;62:111-9.
[85] Hickman JJ, Bhatia SK, Quong JN, Shoen P, Stenger DA, Pike CJ, et al. Rational
pattern design for in vitro cellular networks using surface photochemistry. Journal of
Vacuum Science & Technology A: Vacuum, Surfaces, and Films. 1994;12:607-16.
[86] El-Ali J, Sorger PK, Jensen KF. Cells on chips. Nature. 2006;442:403-11.
[87] Stenger DA, Hickman JJ, Bateman KE, Ravenscroft MS, Ma W, Pancrazio JJ, et al.
Microlithographic determination of axonal/dendritic polarity in cultured hippocampal
neurons. Journal of Neuroscience Methods. 1998;82:167-73.
[88] Ravenscroft MS, Bateman KE, Shaffer KM, Schessler HM, Jung DR, Schneider
TW, et al. Developmental neurobiology implications from fabrication and analysis of
hippocampal neuronal networks on patterned silane-modified surfaces. Journal of the
American Chemical Society. 1998;120:12169-77.

121

[89] Liu Q-Y, Coulombe M, Dumm J, Shaffer KM, Schaffner AE, Barker JL, et al.
Synaptic connectivity in hippocampal neuronal networks cultured on micropatterned
surfaces. Developmental Brain Research. 2000;120:223-31.
[90] Abe K, Chida N, Nishiyama N, Saito H. Spermine promotes the survival of primary
cultured brain neurons. Brain Research. 1993;605:322-6.
[91] Kaeberlein M. Spermidine surprise for a long life. Nat Cell Biol. 2009;11:1277-8.
[92] Eisenberg T, Knauer H, Schauer A, Buttner S, Ruckenstuhl C, Carmona-Gutierrez
D, et al. Induction of autophagy by spermidine promotes longevity. Nat Cell Biol.
2009;11:1305-14.
[93] Zhou FM, Hablitz JJ. Layer I neurons of rat neocortex. I. Action potential and
repetitive firing properties. Journal of Neurophysiology. 1996;76:651-67.
[94] Das M, Molnar P, Devaraj H, Poeta M, Hickman JJ. Electrophysiological and
morphological characterization of rat embryonic motoneurons in a defined system.
Biotechnology Progress. 2003;19:1756-61.
[95] Luckenbill-Edds L. Laminin and the mechanism of neuronal outgrowth. Brain
Research Reviews. 1997;23:1-27.
[96] Powell SK, Kleinman HK. Neuronal laminins and their cellular receptors. The
International Journal of Biochemistry & Cell Biology. 1997;29:401-14.
[97] Natarajan A, DeMarse TB, Molnar P, Hickman JJ. Engineered In Vitro FeedForward Networks. Journal of Biotechnology & Biomaterials. 2013;3.

122

[98] Brewer GJ, Boehler MD, Leondopulos S, Pan L, Alagapan S, DeMarse T, et al.
Toward a self-wired active reconstruction of the hippocampal trisynaptic loop: DG-CA3.
Frontiers in Neural Circuits. 2013;7.
[99] Liu Z, Ren G, Zhang T, Yang Z. Action potential changes associated with the
inhibitory effects on voltage-gated sodium current of hippocampal CA1 neurons by silver
nanoparticles. Toxicology. 2009;264:179-84.
[100] Altemus K, Lavenex P, Ishizuka N, Amaral D. Morphological characteristics and
electrophysiological properties of CA1 pyramidal neurons in macaque monkeys.
Neuroscience. 2005;136:741-56.
[101] Bilkey DK, Schwartzkroin PA. Variation in electrophysiology and morphology of
hippocampal CA3 pyramidal cells. Brain Research. 1990;514:77-83.
[102] Picken Bahrey HL, Moody WJ. Early Development of Voltage-Gated Ion Currents
and Firing Properties in Neurons of the Mouse Cerebral Cortex2003.
[103] Shruti S, Clem RL, Barth AL. A seizure-induced gain-of-function in BK channels is
associated with elevated firing activity in neocortical pyramidal neurons. Neurobiology of
Disease. 2008;30:323-30.
[104] Castro PA, Pleasure SJ, Baraban SC. Hippocampal heterotopia with molecular
and

electrophysiological

properties

of

neocortical

neurons.

Neuroscience.

2002;114:961-72.
[105] Tang-Schomer MD, Davies P, Graziano D, Thurber AE, Kaplan DL. Neural circuits
with long-distance axon tracts for determining functional connectivity. Journal of
Neuroscience Methods.

123

[106] Feldman DH, Thinschmidt JS, Peel AL, Papke RL, Reier PJ. Differentiation of
Ionic Currents in CNS Progenitor Cells: Dependence upon Substrate Attachment and
Epidermal Growth Factor. Experimental Neurology. 1996;140:206-17.
[107] Ding Q, Vaynman S, Akhavan M, Ying Z, Gomez-Pinilla F. Insulin-like growth
factor I interfaces with brain-derived neurotrophic factor-mediated synaptic plasticity to
modulate aspects of exercise-induced cognitive function. Neuroscience. 2006;140:82333.
[108] Clark P. Cell behaviour on micropatterned surfaces. Biosensors and
Bioelectronics. 1994;9:657-61.
[109] Clark P, Britland S, Connolly P. Growth cone guidance and neuron morphology on
micropatterned laminin surfaces. Journal of Cell Science. 1993;105:203-12.
[110] Merkle FT, Alvarez-Buylla A. Neural stem cells in mammalian development.
Current Opinion in Cell Biology. 2006;18:704-9.
[111] Deisseroth K, Singla S, Toda H, Monje M, Palmer TD, Malenka RC. ExcitationNeurogenesis Coupling in Adult Neural Stem/Progenitor Cells. Neuron. 2004;42:535-52.
[112] Lochter A, Schachner M. Tenascin and extracellular matrix glycoproteins: from
promotion to polarization of neurite growth in vitro. The Journal of Neuroscience.
1993;13:3986-4000.
[113] Leng J, Jiang L, Chen H, Zhang X. Brain-derived neurotrophic factor and
electrophysiological properties of voltage-gated ion channels during neuronal stem cell
development. Brain Research. 2009;1272:14-24.

124

[114] Cohen AS, Coussens CM, Raymond CR, Abraham WC. Long-Lasting Increase in
Cellular Excitability Associated With the Priming of LTP Induction in Rat Hippocampus.
Journal of Neurophysiology. 1999;82:3139-48.
[115] Lein PJ, Banker GA, Higgins D. Laminin selectively enhances axonal growth and
accelerates the development of polarity by hippocampal neurons in culture.
Developmental Brain Research. 1992;69:191-7.
[116] Miner JH, Cunningham J, Sanes JR. Roles for Laminin in Embryogenesis:
Exencephaly, Syndactyly, and Placentopathy in Mice Lacking the Laminin α5 Chain.
The Journal of Cell Biology. 1998;143:1713-23.
[117] Liesi P, Dahl D, Vaheri A. Laminin is produced by early rat astrocytes in primary
culture. The Journal of Cell Biology. 1983;96:920-4.
[118] Chiu AY, Espinosa De Los Monteros A, Cole RA, Loera S, De Vellis J. Laminin
and s-laminin are produced and released by astrocytes, schwann cells, and
schwannomas in culture. Glia. 1991;4:11-24.
[119] Cornbrooks CJ, Carey DJ, McDonald JA, Timpl R, Bunge RP. In vivo and in vitro
observations on laminin production by Schwann cells. Proceedings of the National
Academy of Sciences. 1983;80:3850-4.
[120] Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, et al.
Amyloid β-Protein Dimers Isolated Directly from Alzheimer Brains Impair Synaptic
Plasticity and Memory. Nature medicine. 2008;14:837-42.
[121] Tu S, Okamoto S-i, Lipton SA, Xu H. Oligomeric Aβ-induced synaptic dysfunction
in Alzheimer’s disease. Molecular Neurodegeneration. 2014;9:48.

125

[122] Giuffrida ML, Caraci F, Pignataro B, Cataldo S, De Bona P, Bruno V, et al. βAmyloid Monomers Are Neuroprotective. The Journal of Neuroscience. 2009;29:105827.
[123] Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, et al.
Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic
plasticity and memory. Nat Med. 2008;14:837-42.
[124] McGowan E, Pickford F, Kim J, Onstead L, Eriksen J, Yu C, et al. Aβ42 Is
Essential for Parenchymal and Vascular Amyloid Deposition in Mice. Neuron.
2005;47:191-9.
[125] Caughey B, Peter T. Lansbury J. PROTOFIBRILS, PORES, FIBRILS, AND
NEURODEGENERATION: Separating the Responsible Protein Aggregates from The
Innocent Bystanders. Annual Review of Neuroscience. 2003;26:267-98.
[126] Glabe CG. Common mechanisms of amyloid oligomer pathogenesis in
degenerative disease. Neurobiology of Aging. 2006;27:570-5.
[127] Dahlgren KN, Manelli AM, Stine WB, Baker LK, Krafft GA, LaDu MJ. Oligomeric
and Fibrillar Species of Amyloid-β Peptides Differentially Affect Neuronal Viability.
Journal of Biological Chemistry. 2002;277:32046-53.
[128] Gong Y, Chang L, Viola KL, Lacor PN, Lambert MP, Finch CE, et al. Alzheimer's
disease-affected brain: Presence of oligomeric Aβ ligands (ADDLs) suggests a
molecular basis for reversible memory loss. Proceedings of the National Academy of
Sciences. 2003;100:10417-22.
[129] Klyubin I, Betts V, Welzel AT, Blennow K, Zetterberg H, Wallin A, et al. Amyloid β
Protein Dimer-Containing Human CSF Disrupts Synaptic Plasticity: Prevention by
Systemic Passive Immunization. The Journal of Neuroscience. 2008;28:4231-7.
126

[130] Resende R, Ferreiro E, Pereira C, Resende de Oliveira C. Neurotoxic effect of
oligomeric and fibrillar species of amyloid-beta peptide 1-42: Involvement of
endoplasmic reticulum calcium release in oligomer-induced cell death. Neuroscience.
2008;155:725-37.
[131] Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, et al.
Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice.
Science. 1996;274:99-103.
[132] Mayeux R, Tang M-X, Jacobs DM, Manly J, Bell K, Merchant C, et al. Plasma
amyloid β-peptide 1–42 and incipient Alzheimer's disease. Annals of Neurology.
1999;46:412-6.
[133] Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, et al.
Diffusible, nonfibrillar ligands derived from Aβ1–42 are potent central nervous system
neurotoxins. Proceedings of the National Academy of Sciences. 1998;95:6448-53.
[134] Selkoe DJ. Soluble oligomers of the amyloid β-protein impair synaptic plasticity
and behavior. Behavioural Brain Research. 2008;192:106-13.
[135] Choi YJ, Chae S, Kim JH, Barald KF, Park JY, Lee S-H. Neurotoxic amyloid beta
oligomeric assemblies recreated in microfluidic platform with interstitial level of slow
flow. Sci Rep. 2013;3.
[136] Izzo NJ, Staniszewski A, To L, Fa M, Teich AF, Saeed F, et al. Alzheimer's
Therapeutics Targeting Amyloid Beta 1–42 Oligomers I: Abeta 42 Oligomer Binding to
Specific Neuronal Receptors Is Displaced by Drug Candidates That Improve Cognitive
Deficits. PLoS ONE. 2014;9:e111898.

127

[137] Deshpande A, Mina E, Glabe C, Busciglio J. Different Conformations of Amyloid β
Induce Neurotoxicity by Distinct Mechanisms in Human Cortical Neurons. The Journal
of Neuroscience. 2006;26:6011-8.
[138] Carriba P, Jimenez S, Navarro V, Moreno-Gonzalez I, Barneda-Zahonero B,
Moubarak RS, et al. Amyloid-[beta] reduces the expression of neuronal FAIM-L, thereby
shifting the inflammatory response mediated by TNF[alpha] from neuronal protection to
death. Cell Death Dis. 2015;6:e1639.
[139] Minter MR, Main BS, Brody KM, Zhang M, Taylor JM, Crack PJ. Soluble amyloid
triggers a myeloid differentiation factor 88 and interferon regulatory factor 7 dependent
neuronal type-1 interferon response in vitro. Journal of neuroinflammation. 2015;12:71.
[140] Sheikh AM, Michikawa M, Kim SU, Nagai A. Lysophosphatidylcholine increases
the neurotoxicity of Alzheimer’s amyloid β1-42 peptide: Role of oligomer formation.
Neuroscience. 2015;292:159-69.
[141] Chinestra P, Diabira D, Urban NN, Barrionuevo G, Ben-Ari Y. Major differences
between long-term potentiation and ACPD-induced slow onset potentiation in
hippocampus. Neuroscience Letters. 1994;182:177-80.
[142] Bortolotto ZA, Collingridge GL. On the mechanism of long-term potentiation
induced

by

(1S,3R)-1-aminocyclopentane-1,3-dicarboxylic

acid

(ACPD)

in

rat

hippocampal slices. Neuropharmacology. 1995;34:1003-14.
[143] Cirrito JR, May PC, O'Dell MA, Taylor JW, Parsadanian M, Cramer JW, et al. In
vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated
changes in amyloid-beta metabolism and half-life. The Journal of neuroscience : the
official journal of the Society for Neuroscience. 2003;23:8844-53.

128

[144] Riedel G, Reymann KG. Metabotropic glutamate receptors in hippocampal longterm potentiation and learning and memory. Acta Physiologica Scandinavica.
1996;157:1-19.
[145] McGuinness N, Anwyl R, Rowan M. The effects of trans-ACPD on long-term
potentiation in the rat hippocampal slice. NeuroReport. 1991;2:688-90.
[146] Das M, Bhargava N, Gregory C, Riedel L, Molnar P, Hickman JJ. Adult rat spinal
cord culture on an organosilane surface in a novel serum-free medium. In Vitro Cellular
& Developmental Biology-Animal. 2005;41:343-8.
[147] Klein WL. A beta toxicity in Alzheimer's disease: globular oligomers (ADDLs) as
new vaccine and drug targets. Neurochemistry International. 2002;41:345-52.
[148] Li T, Jiang L, Chen H, Zhang X. Characterization of Excitability and Voltage-gated
Ion Channels of Neural Progenitor Cells in Rat Hippocampus. Journal of Molecular
Neuroscience. 2008;35:289-95.
[149] Chai X, Dage JL, Citron M. Constitutive secretion of tau protein by an
unconventional mechanism. Neurobiology of Disease. 2012;48:356-66.
[150] Bloom GS, Ren K, Glabe CG. Cultured cell and transgenic mouse models for tau
pathology linked to β-amyloid. Biochimica et Biophysica Acta (BBA) - Molecular Basis of
Disease. 2005;1739:116-24.
[151] Sproul AA, Jacob S, Pre D, Kim SH, Nestor MW, Navarro-Sobrino M, et al.
Characterization and molecular profiling of PSEN1 familial Alzheimer's disease iPSCderived neural progenitors. PLoS ONE. 2014;9:e84547.

129

[152] Israel MA, Yuan SH, Bardy C, Reyna SM, Mu Y, Herrera C, et al. Probing
sporadic and familial Alzheimer/'s disease using induced pluripotent stem cells. Nature.
2012;482:216-20.
[153] Hossini AM, Megges M, Prigione A, Lichtner B, Toliat MR, Wruck W, et al.
Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer’s
disease donor as a model for investigating AD-associated gene regulatory networks.
BMC Genomics. 2015;16:84.
[154] Biella G, Di Febo F, Goffredo D, Moiana A, Taglietti V, Conti L, et al.
Differentiating embryonic stem–derived neural stem cells show a maturation-dependent
pattern of voltage-gated sodium current expression and graded action potentials.
Neuroscience. 2007;149:38-52.
[155] Mufson EJ, Mahady L, Waters D, Counts SE, Perez SE, DeKosky ST, et al.
Hippocampal plasticity during the progression of Alzheimer’s disease. Neuroscience.
[156] Sperling R, Mormino E, Johnson K. The evolution of preclinical Alzheimer's
disease: Implications for prevention trials. Neuron. 2014;84:608-22.
[157] Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. Toward
defining the preclinical stages of Alzheimer’s disease: Recommendations from the
National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines
for Alzheimer's disease. Alzheimer's & Dementia. 2011;7:280-92.
[158] Wang Y, Zhang G, Zhou H, Barakat A, Querfurth H. Opposite Effects of Low and
High Doses of Aβ42 on Electrical Network and Neuronal Excitability in the Rat Prefrontal
Cortex. PLoS ONE. 2009;4:e8366.

130

[159] Varghese K, Molnar P, Das M, Bhargava N, Lambert S, Kindy MS, et al. A New
Target for Amyloid Beta Toxicity Validated by Standard and High-Throughput
Electrophysiology. PLoS ONE.5:e8643.
[160] Sanganahalli BG, Herman P, Behar KL, Blumenfeld H, Rothman DL, Hyder F.
Functional MRI and neural responses in a rat model of Alzheimer's disease.
NeuroImage. 2013;79:404-11.
[161] Cavanaugh SE, Pippin JJ, Barnard ND. Animal models of Alzheimer disease:
historical pitfalls and a path forward. Altex. 2014;31:279-302.
[162] Kwiat M, Elnathan R, Pevzner A, Peretz A, Barak B, Peretz H, et al. Highly
Ordered Large-Scale Neuronal Networks of Individual Cells – Toward Single Cell to 3D
Nanowire Intracellular Interfaces. ACS Applied Materials & Interfaces. 2012;4:3542-9.
[163] Tang-Schomer MD, White JD, Tien LW, Schmitt LI, Valentin TM, Graziano DJ, et
al. Bioengineered functional brain-like cortical tissue. Proceedings of the National
Academy of Sciences. 2014;111:13811-6.
[164] Cole R, de Vellis J. Preparation of astrocyte, oligodendrocyte, and microglia
cultures from primary rat cerebral cultures. Protocols for neural cell culture: Springer;
2001. p. 117-27.
[165] Odawara A, Saitoh Y, Alhebshi AH, Gotoh M, Suzuki I. Long-term
electrophysiological activity and pharmacological response of a human induced
pluripotent stem cell-derived neuron and astrocyte co-culture. Biochem Biophys Res
Commun. 2014;443:1176-81.
[166] Das M, Bhargava N, Gregory C, Riedel L, Molnar P, Hickman JJ. Adult rat spinal
cord culture on an organosilane surface in a novel serum-free medium. In Vitro Cellular
& Developmental Biology - Animal. 2005;41:343-8.
131

[167] Das M, Wilson K, Molnar P, Hickman JJ. Differentiation of skeletal muscle and
integration of myotubes with silicon microstructures using serum-free medium and a
synthetic silane substrate. Nature Protocols. 2007;2:1795-801.
[168] Berdondini L, Chippalone M, van der Wal PD, Imfeld K, de Rooij NF, KoudelkaHep M, et al. A microelectrode array (MEA) integrated with clustering structures for
investigating in vitro neurodynamics in confined interconnected sub-populations of
neurons. Sensors and Actuators B-Chemical. 2006;114:530-41.
[169] Jimbo Y, Robinson HPC, Kawana A. Strengthening of synchronized activity by
tetanic stimulation in cortical cultures: Application of planar electrode arrays. Ieee
Transactions on Biomedical Engineering. 1998;45:1297-304.
[170] Stenger DA, Hickman JJ, Bateman KE, Ravenscroft MS, Ma W, Pancrazio JJ, et
al. Microlithographic determination of axonal/dendritic polarity in cultured hippocampal
neurons. J Neurosci Methods. 1998;82:167-73.
[171] Dworak BJ, Wheeler BC. Novel MEA platform with PDMS microtunnels enables
the detection of action potential propagation from isolated axons in culture. Lab Chip.
2009;9:404-10.
[172] Liangbin P, Sankaraleengam A, Eric F, Gregory JB, Bruce CW. Propagation of
action potential activity in a predefined microtunnel neural network. Journal of Neural
Engineering. 2011;8:046031.
[173] Xu X, Lei Y, Luo J, Wang J, Zhang S, Yang X-J, et al. Prevention of β-amyloid
induced toxicity in human iPS cell-derived neurons by inhibition of Cyclin-dependent
kinases and associated cell cycle events. Stem Cell Research. 2013;10:213-27.

132

[174] Han Z, Jin L, Platisa J, Cohen LB, Baker BJ, Pieribone VA. Fluorescent Protein
Voltage Probes Derived from ArcLight that Respond to Membrane Voltage Changes
with Fast Kinetics. PLoS ONE. 2013;8:e81295.
[175] Fenno L, Yizhar O, Deisseroth K. The Development and Application of
Optogenetics. Annual Review of Neuroscience. 2011;34:389-412.
[176] Momose-Sato Y, Sato K, Arai Y, Yazawa I, Mochida H, Kamino K. Evaluation of
Voltage-Sensitive Dyes for Long-Term Recording of Neural Activity in the Hippocampus.
J Membrane Biol. 1999;172:145-57.
[177] Ohta M, Saito T, Saito K, Kurasaki M, Hosokawa T. Effect of Trichloroethylene on
Spatiotemporal Pattern of LTP in Mouse Hippocampal Slices. International Journal of
Neuroscience. 2001;111:257-71.
[178] Park TH, Shuler ML. Integration of cell culture and microfabrication technology.
Biotechnology Progress. 2003;19:243-53.
[179] Selkoe DJ. Alzheimer's disease is a synaptic failure. Science. 2002;298:789-91.
[180] Materne EM, Ramme AP, Terrasso AP, Serra M, Alves PM, Brito C, et al. A multiorgan chip co-culture of neurospheres and liver equivalents for long-term substance
testing. Journal of biotechnology. 2015;205:36-46.
[181] Maschmeyer I, Lorenz AK, Schimek K, Hasenberg T, Ramme AP, Hubner J, et al.
A four-organ-chip for interconnected long-term co-culture of human intestine, liver, skin
and kidney equivalents. Lab Chip. 2015;15:2688-99.
[182] Tourovskaia A, Fauver M, Kramer G, Simonson S, Neumann T. Tissueengineered microenvironment systems for modeling human vasculature. Experimental
biology and medicine (Maywood, NJ). 2014;239:1264-71.
133

134

